Revised. Amendments from Version 1
==================================

In this revised version of our workflow, we made the following major changes: - The introduction now includes the GDC NCI data portal ( <https://gdc.nci.nih.gov/>). - The codes to acquire TCGA data were rewritten in order to use the new version of the TCGAbiolinks package. TCGAbiolinks was entirely redesigned to query, download and prepare data from the GDC NCI data portal ( <https://gdc.nci.nih.gov/>) instead of the inactive DCC TCGA data portal ( <https://tcga-data.nci.nih.gov>). Minor changes includes improvements based on the referee\'s comments, such as: - The inclusion of a paragraph to introduce GISTIC data - The inclusion of a paragraph explaining the differences between the open (TCGA level 3 and 4 data) and controlled data (TCGA level 1 and 2 data) and pointing to sources that might help the user request access to controlled data. - Hyperlinks and references were corrected. - Improvements in the text by removing a few redundancies. - We used data aligned to reference genome hg19 in all steps of the workflow.

Introduction
============

Cancer is a complex genetic disease spanning multiple molecular events such as point mutations, structural variations, translocations and activation of epigenetic and transcriptional signatures and networks. The effects of these events take place at different spatial and temporal scales with interlayer communications and feedback mechanisms creating a highly complex dynamic system. To gain insight into the biology of tumors most of the research in cancer genomics is aimed at the integration of the observations at multiple molecular scales and the analysis of their interplay. Even if many tumors share similar recurrent genomic events, their relationships with the observed phenotype are often not understood. For example, although we know that the majority of the most aggressive form of brain tumors such as glioma harbor the mutation of a single gene (IDH), the mechanistic explanation of the activation of its characteristic epigenetic and transcriptional signatures are still far to be well characterized. Moreover, network-based strategies have recently emerged as an effective framework for the discovery functional disease drivers that act as main regulators of cancer phenotypes.

Indeed, recent technological developments allowed the deposition of large amounts of genomic and epigenomic data, such as gene expression, DNA methylation, and genomic localization of transcription factors, into freely available public international consortia like The Cancer Genome Atlas ( [TCGA](http://cancergenome.nih.gov/)), The Encyclopedia of DNA Elements ( [ENCODE](https://www.encodeproject.org)), and The NIH Roadmap Epigenomics Mapping Consortium ( [Roadmap](http://www.roadmapepigenomics.org)) ^[@ref-1]^. An overview of the three consortia is described below: **The Cancer Genome Atlas (TCGA):** The TCGA consortium, which is a National Institute of Health (NIH) initiative, makes publicly available molecular and clinical information for more than 30 types of human cancers including exome (variant analysis), single nucleotide polymorphism (SNP), DNA methylation, transcriptome (mRNA), microRNA (miRNA) and proteome. Sample types available at TCGA are: primary solid tumors, recurrent solid tumors, blood derived normal and tumor, metastatic, and solid tissue normal ^[@ref-2]^.**The Encyclopedia of DNA Elements (ENCODE):** Found in 2003 by the National Human Genome Research Institute (NHGRI), the project aims to build a comprehensive list of functional elements that have an active role in the genome, including regulatory elements that govern gene expression. Biosamples includes immortalized cell lines, tissues, primary cells and stem cells ^[@ref-3]^.**The NIH Roadmap Epigenomics Mapping Consortium:** This was launched with the goal of producing a public resource of human epigenomic data in order to analyze biology and disease-oriented research. Roadmap maps DNA methylation, histone modifications, chromatin accessibility, and small RNA transcripts in stem cells and primary *ex vivo* tissues ^[@ref-4],\ [@ref-5]^.

Briefly, these three consortia provide large scale epigenomic data onto a variety of microarrays and next-generation sequencing (NGS) platforms. Each consortium encompasses specific types of biological information on specific type of tissue or cell and when analyzed together, it provides an invaluable opportunity for research laboratories to better understand the developmental progression of normal cells to cancer state at the molecular level and importantly, correlate these phenotypes with tissue of origins.

Although there exists a wealth of possibilities ^[@ref-6]^ in accessing cancer associated data, [Bioconductor](http://www.bioconductor.org) represent the most comprehensive set of open source, updated and integrated professional tools for the statistical analysis of large scale genomic data. Thus, we propose our workflow within Bioconductor to describe how to download, process, analyze and integrate cancer data to understand specific cancer-related specific questions. However, there is no tool that solves the issue of integration in a comprehensive sequence and mutation information, epigenomic state and gene expression within the context of gene regulatory networks to identify oncogenic drivers and characterize altered pathways during cancer progression. Therefore, our workflow presents several [Bioconductor](http://www.bioconductor.org) packages to work with genomic and epigenomics data.

Methods
=======

Access to the data
------------------

TCGA data is accessible via the the NCI Genomic Data Commons (GDC) [data portal](https://gdc-portal.nci.nih.gov/), [GDC Legacy Archive](https://gdc-portal.nci.nih.gov/legacy-archive/search/f) and the [Broad Institute's GDAC Firehose](http://gdac.broadinstitute.org). The GDC Data Portal provides access to the subset of TCGA data that has been harmonized against GRCh38 (hg38) using GDC Bioinformatics Pipelines which provides methods to the standardization of biospecimen and clinical data, the re-alignment of DNA and RNA sequence data against a common reference genome build GRCh38, and the generation of derived data. Whereas the GDC Legacy Archive provides access to an unmodified copy of data that was previously stored in [CGHub](https://cghub.ucsc.edu/) ^[@ref-7]^ and in the TCGA Data Portal hosted by the TCGA Data Coordinating Center (DCC), in which uses as references GRCh37 (hg19) and GRCh36 (hg18).

The previously stored data in CGHub, TCGA Data Portal and Broad Institute's GDAC Firehose, were provided as different levels or tiers that were defined in terms of a specific combination of both processing level (raw, normalized, integrated) and access level (controlled or open access). Level 1 indicated raw and controlled data, level 2 indicated processed and controlled data, level 3 indicated Segmented or Interpreted Data and open access and level 4 indicated region of interest and open access data. While the TCGA data portal provided level 1 to 3 data, Firehose only provides level 3 and 4. An explanation of the different levels can be found at [TCGA Wiki](https://wiki.nci.nih.gov/display/TCGA/Data+level). However, the GDC data portal no longer uses this based classification model in levels. Instead a new data model was created, its documentation can be found in [GDC documentation](https://gdc.nci.nih.gov/developers/gdc-data-model/gdc-data-model-components). In this new model, data can be open or controlled access. While the GDC open access data does not require authentication or authorization to access it and generally includes high level genomic data that is not individually identifiable, as well as most clinical and all biospecimen data elements, the GDC controlled access data requires dbGaP authorization and eRA Commons authentication and generally includes individually identifiable data such as low level genomic sequencing data, germline variants, SNP6 genotype data, and certain clinical data elements. The process to obtain access to controlled data is found in [GDC web site](https://gdc.nci.nih.gov/access-data/obtaining-access-controlled-data).

Finally, the data provided by [GDC data portal](https://gdc-portal.nci.nih.gov/) and [GDC Legacy Archive](https://gdc-portal.nci.nih.gov/legacy-archive/search/f) can be accessed using Bioconductor package [TCGAbiolinks](http://bioconductor.org/packages/TCGAbiolinks/), while the data provided by Firehose can be accessed by Bioconductor package [RTCGAToolbox](http://bioconductor.org/packages/RTCGAToolbox/).

The next steps describes how one could use [TCGAbiolinks](http://bioconductor.org/packages/TCGAbiolinks/) & [RTCGAToolbox](http://bioconductor.org/packages/RTCGAToolbox/) to download clinical, genomics, transcriptomics, epigenomics data, as well as subtype information and GISTIC results (i.e., identified genes targeted by somatic copy-number alterations (SCNAs) that drive cancer growth). All the data used in this workflow has as reference the Genome Reference Consortium human genome (build 37 - hg19).

***Downloading data from TCGA data portal.*** The Bioconductor package [TCGAbiolinks](http://bioconductor.org/packages/TCGAbiolinks/) ^[@ref-8]^ has three main functions *GDCquery*, *GDCdownload* and *GDCprepare* that should sequentially be used to respectively search, download and load the data as an R object. *GDCquery* uses [GDC API](https://gdc.cancer.gov/developers/gdc-application-programming-interface-api) to search the data for a given project and data category and filters the results by samples, sample type, file type and others features if requested by the user. This function returns a object with a summary table with the results found (samples, files and other useful information) and the arguments used in the query. The most important *GDCquery* arguments are *project* which receives a GDC project (TCGA-USC, TCGA-LGG, TARGET-AML, etc), *data.category* which receives a data category (Transcriptome Profiling, Copy Number Variation, DNA methylation, Gene expression, etc), *data.type* which receives a data type (Gene expression quantification, Isoform Expression Quantification, miRNA Expression Quantification, Copy Number Segment, Masked Copy Number Segment, etc), *workflow.type*, which receives a GDC workflow type (HTSeq - Counts, HTSeq - FPKM-UQ, HTSeq - FPKM), *legacy*, which selects to use the legacy database or the harmonized database, *file.type*, which receives a file type for the searches in the legacy database (hg18.seg, hg19.seg, nocnv\_,hg18.seg, nocnv_hg19.seg, rsem.genes.results, rsem.genes.normalized_results, etc) and *platform*, which receives a the platform for the searches in the legacy database (HumanMethylation27, Genome_Wide_SNP_6, IlluminaHiSeq_RNASeqV2, etc). A complete list of possible entries for arguments can be found in the [TCGAbiolinks vignette](https://www.bioconductor.org/packages/3.3/bioc/vignettes/TCGAbiolinks/inst/doc/tcgaBiolinks.html#harmonized-data-1). [Listing 1](#l1){ref-type="other"} shows an example of this function.

After the search step, the user will be able to download the data using the *GDCdownload* function which can use either the GDC API to download the samples, or the [gdc client tools](https://gdc.cancer.gov/access-data/gdc-data-transfer-tool). The downloaded data will be saved in a directory with the project name and a sub-folder with the data.category, for example "TCGA-GBM/DNA_methylation".

Finally, *GDCprepare* transforms the downloaded data into a [summarizedExperiment](http://bioconductor.org/packages/SummarizedExperiment/) object ^[@ref-9]^ or a data frame. If *SummarizedExperiment* is set to TRUE, TCGAbiolinks will add to the object sub-type information, which was defined by The Cancer Genome Atlas (TCGA) Research Network reports (the full list of papers can be seen in [TCGAquery_subtype section](http://bioconductor.org/packages/devel/bioc/vignettes/TCGAbiolinks/inst/doc/tcgaBiolinks.html#tcgaquery_subtype-working-with-molecular-subtypes-data) in TCGAbiolinks vignette), and clinical information. [Listing 1](#l1){ref-type="other"} shows how to use these functions to download DNA methylation and gene expression data from the GDC legacy database and 2 shows how to download copy number variation from harmonized data portal. Other examples, that access the harmonized data can be found in the [TCGAbiolinks vignette](https://www.bioconductor.org/packages/3.3/bioc/vignettes/TCGAbiolinks/inst/doc/tcgaBiolinks.html).

1 library (TCGAbiolinks) 2 3 \# Obs: The data in the legacy database has been aligned to hg19 4 query.met.gbm \<-- GDCquery(project = \"TCGA--GBM\" , 5 legacy = TRUE, 6 data . category = \"DNA methylation\" , 7 platform = \"Illumina Human Methylation 450\" , 8 barcode = c ( \"TCGA--76--4926--01B--01D--1481--05\" , \"TCGA--28--5211--01C--11D--1844--05\" )) 9 GDCdownload(query.met.gbm) 10 11 met.gbm.450 \<-- GDCprepare(query = query.met.gbm, 12 save = TRUE, 13 save .filename = \"gbmDNAmet450k.rda\" , 14 summarizedExperiment = TRUE) 15 query.met.lgg \<-- GDCquery(project = \"TCGA--LGG\" , 16 legacy = TRUE, 17 data . category = \"DNA methylation \" , 18 platform = \"Illumina Human Methylation 450\" , 19 barcode = c ( \"TCGA--HT--7879--01A--11D--2399--05\" , \"TCGA--HT--8113--01A--11D--2399--05\" ) ) 20 GDCdownload(query.met.lgg) 21 met.lgg.450 \<-- GDCprepare(query = query.met.lgg, 22 save = TRUE, 23 save .filename = \"lggDNAmet450k.rda\" , 24 summarizedExperiment = TRUE) 25 met.gbm.lgg \<-- SummarizedExperiment:: cbind (met.lgg.450, met.gbm.450) 26 27 28 query. exp .lgg \<-- GDCquery(project = \"TCGA--LGG\" , 29 legacy = TRUE, 30 data . category = \"Gene expression\" , 31 data .type = \"Gene expression quantification\" , 32 platform = \"Illumina HiSeq\" , 33 file .type = \"results\" , 34 sample .type = \"Primary solid Tumor\" ) 35 GDCdownload(query. exp .lgg) 36 exp .lgg \<-- GDCprepare(query = query. exp .lgg, save = TRUE, save .filename = \"lggExp.rda\" ) 37 38 query. exp .gbm \<-- GDCquery(project = \"TCGA--GBM\" , 39 legacy = TRUE, 40 data . category = \"Gene expression\" , 41 data .type = \"Gene expression quantification\" , 42 platform = \"Illumina HiSeq\" , 43 file .type = \"results\" , 44 sample .type = \"Primary solid Tumor\" ) 45 GDCdownload(query. exp .gbm) 46 exp .gbm \<-- GDCprepare(query = query. exp .gbm, save = TRUE, save .filename = \"gbmExp.rda\" ) 47 exp .gbm.lgg \<-- SummarizedExperiment:: cbind ( exp .lgg, exp .gbm)

**Listing 1. Downloading TCGA DNA methylation and gene expression data from GDC legacy database with TCGAbiolinks**

1 library (TCGAbiolinks) 2 \#------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ 3 \# Data.category: Copy number variation aligned to hg38 4 \#------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ 5 query \<-- GDCquery(project = \"TCGA--ACC\" , 6 data . category = \"Copy Number Variation\" , 7 data .type = \"Copy Number Segment\" , 8 barcode = c ( \"TCGA--OR--A5KU--01A--11D--A29H--01\" , \"TCGA--OR--A5JK--01A--11D--A29H--01\" )) 9 GDCDownload(query) 10 data \<-- GDCPrepare(query) 11 12 query \<-- GDCquery( \"TCGA--ACC\" , 13 \"Copy Number Variation\" , 14 data .type = \"Masked Copy Number Segment\" , 15 sample .type = c ( \"Primary solid Tumor\" )) \# see the barcodes with query \$ results\[\[1\]\] \$ cases 16 GDCDownload(query) 17 data \<-- GDCPrepare(query)

**Listing 2. Downloading TCGA copy number variation data from GDC harmonized database with TCGAbiolinks**

If a summarizedExperiment object was chosen, the data can be accessed with three different accessors: *assay* for the data information, *rowRanges* to gets the range of values in each row and *colData* to get the sample information (patient, batch, sample type, etc) ^[@ref-9],\ [@ref-10]^. An example is shown in [Listing 3](#l3){ref-type="other"}.

1 library (summarizedExperiment) 2 \# get expression matrix 3 data \<-- assay( exp .gbm.lgg) 4 5 \# get genes information 6 genes.info \<-- rowRanges( exp .gbm.lgg) 7 8 \# get sample information 9 sample .info \<-- colData( exp .gbm.lgg)

**Listing 3. summarizedExperiment accessors**

The clinical data can be obtained using TCGAbiolinks through two methods. The first one will download only the indexed GDC clinical data which includes diagnoses (vital status, days to death, age at diagnosis, days to last follow up, days to recurrence), treatments (days to treatment, treatment id, therapeutic agents, treatment intent type), demographic (gender, race, ethnicity) and exposures (cigarettes per day, weight, height, alcohol history) information. This indexed clinical data can be obtained using the function *GDCquery_clinical* which can be used as described in [Listing 4](#l4){ref-type="other"}. This function has two arguments *project* (\"TCGA-GBM\",\"TARGETAML\", etc) and *type* (\"Clinical\" or \"Biospecimen\"). The second method will download the xml files with all clinical data for the patient and retrieve the desired information from it. This will give access to all clinical data available which includes patient (tumor tissue site, histological type, gender, vital status, days to birth, days to last follow up, etc), drug (days to drug therapy start, days to drug therapy end, therapy types, drug name), radiation (days to radiation therapy start, days to radiation therapy end, radiation type, radiation dosage), new tumor event (days to new tumor event after initial treatment, new neoplasm event type, additional pharmaceutical therapy), follow up (primary therapy outcome success, follow up treatment success, vital status, days to last follow up, date of form completion), stage event (pathologic stage, tnm categories), admin (batch number, project code, disease code, Biospecimen Core Resource).

1 \# get indexed clinical patient data for GBM samples 2 gbm \_ clin \<-- GDCquery \_ clinic(project = \"TCGA--GBM\" , type = \"Clinical\" ) 3 4 \# get indexed clinical patient data for LGG samples 5 lgg \_ clin \<-- GDCquery \_ clinic(project = \"TCGA--LGG\" , type = \"Clinical\" ) 6 7 \# Bind the results, as the columns might not be the same, 8 \# we will will plyr rbind.fill, to have all columns from both files 9 clinical \<-- plyr:: rbind .fill(gbm \_ clin,lgg \_ clin) 10 11 \# if barcode is not set, it will consider all samples. 12 \# We only set it to make the example faster 13 query.clin \<-- GDCquery(project = \"TCGA--GBM\" , 14 data . category = \"Clinical\" , 15 barcode = c ( \"TCGA--08--0516\" , \"TCGA--02--0317\" )) 16 GDCDownload(query.clin) 17 clinical.patient \<-- GDCPrepare \_ clinic(query, \"patient\" ) 18 clinical.drug \<-- GDCPrepare \_ clinic(query, \"drug\" ) 19 clinical.radiation \<-- GDCPrepare \_ clinic(query, \"radiation\" ) 20 clinical.admin \<-- GDCPrepare \_ clinic(query, \"admin\" ) 21 clinical.followup \<-- GDCPrepare \_ clinic(query, \"follow \_ up\" ) 22 clinical.nte \<-- GDCPrepare \_ clinic(query, \"new \_ tumor \_ event\" ) 23 clinical.stage \<-- GDCPrepare \_ clinic(query, \"stage \_ event\" )

**Listing 4. Downloading clinical data with TCGAbiolinks**

Mutation information is stored in two types of Mutation Annotation Format (MAF): Protected and Somatic (or Public) MAF files, which are derived from the GDC annotated VCF files. Annotated VCF files often have variants reported on multiple transcripts whereas the protected MAF (\*protected.maf) only reports the most critically affected one and the Somatic MAFs (\*somatic.maf) are further processed to remove low quality and potential germline variants. To download Somatic MAFs data using [TCGAbiolinks](http://bioconductor.org/packages/TCGAbiolinks/), *GDCquery_maf* function is provided (see [Listing 5](#l5){ref-type="other"}).

1 mutation \<-- GDCquery \_ Maf(tumor = \"ACC\" , pipelines = \"mutect2\" )

**Listing 5. Downloading mutation data with TCGAbiolinks**

Finally, the Cancer Genome Atlas (TCGA) Research Network has reported integrated genome-wide studies of various diseases (ACC ^[@ref-11]^, BRCA ^[@ref-12]^, COAD ^[@ref-13]^, GBM ^[@ref-14]^, HNSC ^[@ref-15]^, KICH ^[@ref-16]^, KIRC ^[@ref-17]^, KIRP ^[@ref-18]^, LGG ^[@ref-14]^, LUAD ^[@ref-19]^, LUSC ^[@ref-20]^, PRAD ^[@ref-21]^, READ ^[@ref-13]^, SKCM ^[@ref-22]^, STAD ^[@ref-23]^, THCA ^[@ref-24]^ and UCEC ^[@ref-23]^) which classified them in different subtypes. This classification can be retrieved using the *TCGAquery_subtype* function or by accessing the samples information in the SummarizedExperiment object that created by the *GDCprepare* function.

1 gbm.subtypes \<-- TCGAquery \_ subtype(tumor = \"gbm\" ) 2 brca.subtypes \<-- TCGAquery \_ subtype(tumor = \"brca\" )

**Listing 6. Accessing subtype information retrieved from TCGA papers**

***Downloading data from Broad TCGA GDAC.*** The Bioconductor package [RTCGAToolbox](http://bioconductor.org/packages/RTCGAToolbox/) ^[@ref-25]^ provides access to Firehose Level 3 and 4 data through the function *getFirehoseData*. The following arguments allows users to select the version and tumor type of interest: •dataset - Tumor to download. A complete list of possibilities can be viewed with *getFirehoseDatasets* function.•runDate - Stddata run dates. Dates can be viewed with *getFirehoseRunningDates* function.•gistic2_Date - Analyze run dates. Dates can viewed with *getFirehoseAnalyzeDates* function.

These arguments can be used to select the data type to download: RNAseq_Gene, Clinic, miRNASeq_Gene, ccRNAseq2_Gene_Norm, CNA_SNP, CNV_SNP, CNA_Seq, CNA_CGH, Methylation, Mutation, mRNA_Array, miRNA_Array, and RPPA.

By default, [RTCGAToolbox](http://bioconductor.org/packages/RTCGAToolbox/) allows users to download up to 500 MB worth of data. To increase the size of the download, users are encouraged to use *fileSizeLimit* argument. An example is found in [Listing 7](#l7){ref-type="other"}. The *getData* function allow users to access the downloaded data (see lines 22--24 of [Listing 7](#l7){ref-type="other"}) as a S4Vector object.

1 library (RTCGAToolbox) 2 3 \# Get the last run dates 4 lastRunDate \<- getFirehoseRunningDates()\[1\] 5 lastAnalyseDate \<- getFirehoseAnalyzeDates(1) 6 7 \# get DNA methylation data, RNAseq2 and clinical data for LGG 8 lgg. data \<- getFirehoseData(dataset = \"LGG\" , 9 gistic2 \_ Date = getFirehoseAnalyzeDates(1), runDate = lastRunDate, 10 Methylation = TRUE, RNAseq2 \_ Gene \_ Norm = TRUE, Clinic = TRUE, 11 Mutation = T, 12 fileSizeLimit = 10000) 13 14 \# get DNA methylation data, RNAseq2 and clinical data for GBM 15 gbm. data \<- getFirehoseData(dataset = \"GBM\" , 16 runDate = lastDate, gistic2 \_ Date = getFirehoseAnalyzeDates(1), 17 Methylation = TRUE, Clinic = TRUE, RNAseq2 \_ Gene \_ Norm = TRUE, 18 fileSizeLimit = 10000) 19 20 \# To access the data you should use the getData function 21 \# or simply access with @ (for example gbm.data\@Clinical) 22 gbm.mut \<- getData(gbm. data , \"Mutations\" ) 23 gbm.clin \<- getData(gbm. data , \"Clinical\" ) 24 gbm.gistic \<- getData(gbm. data , \"GISTIC\" )

**Listing 7. Downloading TCGA data files with RTCGAToolbox**

Finally, using [RTCGAToolbox](http://bioconductor.org/packages/RTCGAToolbox/) the user can retrieve CNV level 4 data, including the amplified or deleted genes identified by GISTIC which rates each segment based on the frequency of occurrence combined with the amplitude of aberration, using a permutation test to assess the statistical significance. Among GISTIC results there are two tables that can be accessed by [RTCGAToolbox](http://bioconductor.org/packages/RTCGAToolbox/): A gene-level table of copy number values for all samples. The copy number values in the table are in units of (copy number -2), so that no amplification or deletion is 0, genes with amplifications have positive values, and genes with deletions are negative values. The data are converted from marker level to gene level using the extreme method: a gene is assigned the greatest amplification or the least deletion value among the markers it covers.A gene-level table of discrete amplification and deletion indicators for all samples. A table value of 0 means no amplification or deletion above the threshold (diploid normal copy). Amplifications are positive numbers: 1 means amplification above the amplification threshold (low-level gain, 1 extra copy); 2 means amplifications larger to the arm level amplifications observed for the sample (high-level amplification, 2 or more extra copies). Deletions are represented by negative table values: -1 represents deletion beyond the threshold (possibly a heterozygous deletion); -2 means deletions greater than the minimum arm-level deletion observed for the sample (possibly a homozygous deletion).

More details about the GISTIC algorithm and its use are described in [@ref-26]-- [@ref-28]. (see [Listing 8](#l8){ref-type="other"}).

1 \# Download GISTIC results 2 gistic \<- getFirehoseData( \"GBM\" ,gistic2 \_ Date = \"20141017\" ) 3 4 \# get GISTIC results 5 gistic.allbygene \<- gistic\@GISTIC\@AllByGene 6 gistic.thresholedbygene \<- gistic\@GISTIC\@ThresholedByGene

**Listing 8. Using RTCGAToolbox to get the GISTIC results**

Genomic analysis
----------------

Copy number variations (CNVs) have a critical role in cancer development and progression. A chromosomal segment can be deleted or amplified as a result of genomic rearrangements, such as deletions, duplications, insertions and translocations. CNVs are genomic regions greater than 1 kb with an alteration of copy number between two conditions (e.g., Tumor *versus* Normal).

TCGA collects copy number data and allows the CNV profiling of cancer. Tumor and paired-normal DNA samples were analyzed for CNV detection using microarray and sequencing-based technologies. Level 3 processed data are the aberrant regions along the genome resulting from CNV segmentation, and they are available for all copy number technologies.

In this section, we will show how to analyze CNV level 3 data from TCGA to identify recurrent alterations in cancer genome. We analyzed GBM and LGG segmented CNV from SNP array (Affymetrix Genome-Wide Human SNP Array 6.0).

***Pre-Processing data.*** The only CNV platform available for both LGG and GBM in TCGA is \"Affymetrix Genome-Wide Human SNP Array 6.0\". Using TCGAbiolinks, we queried for CNV SNP6 level 3 data for primary solid tumor samples in the legacy database. Data for selected samples were downloaded and prepared in two separate rse objects (RangedSummarizedExperiment).

1 \#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\# 2 \#\# CNV data pre--processing \#\# 3 \#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\# 4 library (TCGAbiolinks) 5 6 query.lgg.nocnv \<-- GDCquery(project = \"TCGA--LGG\" , 7 data . category = \"Copy number variation\" , 8 legacy = TRUE, 9 file .type = \"nocnv \_ hg19.seg\" , 10 sample .type = c ( Primary solid Tumor\" )) 11 GDCdownload(query.lgg.nocnv) 12 lgg.nocnv \<-- GDCprepare(query.lgg.nocnv, save = TRUE, save .filename = \"LGGnocnvhg19.rda\" ) 13 14 query.gbm.nocnv \<-- GDCquery(project = \"TCGA--GBM\" , 15 data . category = \"Copy number variation\" , 16 legacy = TRUE, 17 file . type = \"nocnv \_ hg19.seg\" , 18 sample .type = c ( \"Primary solid Tumor\" )) 19 GDCdownload(query.gbm.nocnv) 20 gbm.nocnv \<-- GDCprepare (query.gbm.nocnv, save = TRUE, save .file name = \"GBMnocnvhg19.rda\" )

**Listing 9. Searching, downloading and preparing CNV data with TCGAbiolinks**

***Identification of recurrent CNV in cancer.*** Cancer related CNV have to be present in many of the analyzed genomes. The most significant recurrent CNV were identified using [GAIA](http://bioconductor.org/packages/gaia/) ^[@ref-29]^, an iterative procedure where a statistical hypothesis framework is extended to take into account within-sample homogeneity. GAIA is based on a conservative permutation test allowing the estimation of the probability distribution of the contemporary mutations expected for non-driver markers. Segmented data retrieved from TCGA were used to generate a matrix including all needed information about the observed aberrant regions. Furthermore, GAIA requires genomic probes metadata (specific for each CNV technology), that can be downloaded from broadinstitute website.

1 \#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\# 2 \#\# CNV data pre--processing \#\# 3 \#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\# 4 library (TCGAbiolinks) 5 library (downloader) 6 library (readr) 7 library (gaia) 8 9 gaiaCNVplot \<-- function (calls, cancer=NULL, threshold=0.01) 10 { 11 Calls \<-- calls\[ order (calls\[, \"Region Start\[bp\]\" \]),\] 12 Calls \<-- Calls\[ order (Calls\[, \"Chromosome\" \]),\] 13 rownames (Calls) \<-- NULL 14 Chromo \<-- Calls\[, \"Chromosome\" \] 15 Gains \<-- apply (Calls,1, function (x) ifelse (x\[ \"Aberration Kind\" \]==1, x\[ \"score\" \], 0)) 16 Losses \<-- apply (Calls,1, function (x) ifelse (x\[ \"Aberration Kind\" \]==0, x\[ \"score\" \], 0)) 17 plot (Gains, ylim = c (-- max (Calls\[, \"score\" \]+2), max (Calls\[, \"score\" \]+2)), type = \"h\" , 18 col = \"red\" , xlab = \"Chromosome\" , ylab = \"Score\" , 19 \#main = paste(\"Recurrent Copy Number Variations\",cancer, sep =\" -- \"), 20 xaxt = \"n\" ) 21 points (--(Losses), type = \"h\" , col = \"blue\" ) 22 abline (h = 0, cex = 4) 23 abline (h = -- log10 (threshold), col = \"orange\" , cex = 4, main= \"test\" ) 24 abline (h = log10 (threshold), col = \"orange\" , cex = 4, main= \"test\" ) 25 uni.chr \<-- unique (Chromo) 26 temp \<-- rep (0, length (uni.chr)) 27 for (i in 1 : length (uni.chr)) { 28 temp\[i\] \<-- max ( which (uni.chr\[i\] == Chromo)) 29 } 30 for (i in 1: length (temp)) { 31 abline (v = temp\[i\], col = \"black\" , lty = \"dashed\" , ) 32 } 33 nChroms \<-- length (uni.chr) 34 begin \<-- c () 35 for (d in 1: nChroms) { 36 chrom \<-- sum (Chromo == uni.chr\[d\]) 37 begin \<-- append (begin, chrom) 38 } 39 temp2 \<-- rep (0, nChroms) 40 for (i in 1:nChroms) { 41 if (i == 1) { 42 temp2\[1\] \<-- (begin\[1\] \* 0.5) 43 } 44 else if (i \> 1) { 45 temp2\[i\] \<-- temp\[i -- 1\] + (begin\[i\] \* 0.5) 46 } 47 } 48 uni.chr\[uni.chr ==23\] \<-- \"X\" 49 uni.chr\[uni.chr ==24\] \<-- \"Y\" 50 for (i in 1: length (temp)) { 51 axis (1, at = temp2\[i\], labels = uni.chr\[i\], cex. axis = 1) 52 } 53 legend (x=1, y= max (Calls\[, \"score\" \]+2), y.intersp=0.8, c ( \"Amp\" ), pch=15, col = c ( \"red\" ), text .font=3) 54 legend (x=1,y=-- max (Calls\[, \"score\" \]+0.5), y.intersp=0.8, c ( \"Del\" ), pch=15, col = c ( \"blue\" ), text .font=3) 55 } 56 57 58 for (cancer in c ( \"LGG\" , \"GBM\" )){ 59 message(paste0( \"Starting\" , cancer)) 60 \# Prepare CNV matrix 61 cnvMatrix \<-- get ( load (paste0 (cancer, \"nocnvhg19.rda\" ))) 62 63 \# Add label (0 for loss, 1 for gain) 64 cnvMatrix \<-- cbind (cnvMatrix, Label=NA) 65 cnvMatrix\[cnvMatrix\[, \"Segment \_ Mean\" \] \< --0.3, \"Label\" \] \<-- 0 66 cnvMatrix\[cnvMatrix\[, \"Segment \_ Mean\" \] \> 0.3, \"Label\" \] \<-- 1 67 cnvMatrix \<-- cnvMatrix\[ !is . na (cnvMatrix \$ Label),\] 68 69 \# Remove \" Segment \_ Mean\" and change col.names 70 cnvMatrix \<-- cnvMatrix\[,--6\] 71 colnames (cnvMatrix) \<-- c ( \"Sample.Name\" , \"Chromosome\" , \"Start\" , \"End\" , \"Num.of.Markers\" , \"Aberration\" ) 72 73 \# Substitute Chromosomes \"X\" and \"Y\" with \"23\" and \"24\" 74 xidx \<-- which (cnvMatrix \$ Chromosome== \"X\" ) 75 yidx \<-- which (cnvMatrix \$ Chromosome== \"Y\" ) 76 cnvMatrix\[xidx, \"Chromosome\" \] \<-- 23 77 cnvMatrix\[yidx, \"Chromosome\" \] \<- 24 78 cnvMatrix \$ Chromosome \<- sapply (cnvMatrix \$ Chromosome, as . integer ) 79 80 \# Recurrent CNV identification with GAIA 81 82 \# Retrieve probes meta file from broadinstitute website 83 \# Recurrent CNV identification with GAIA 84 gdac.root \<- \"ftp: // ftp.broadinstitute.org / pub / GISTIC2.0 / hg19 \_ support / \" 85 file \<- paste0(gdac.root, \"genome.info.6.0 \_ hg19.na31 \_ minus \_ frequent \_ nan \_ probes \_ sorted \_ 2.1.txt\" ) 86 \# Retrieve probes meta file from broadinstitute website 87 if ( !file. exists ( basename ( file ))) download ( file , basename ( file )) 88 markersMatrix \<- readr:: read\_ tsv( basename ( file ), col_names = FALSE, col\_ types = \"ccn\" , progress = TRUE) 89 colnames (markersMatrix) \<- c ( \"Probe.Name\" , \"Chromosome\" , \"Start\" ) 90 unique (markersMatrix \$ Chromosome) 91 xidx \<- which (markersMatrix \$ Chromosome== \"X\" ) 92 yidx \<- which (markersMatrix \$ Chromosome== \"Y\" ) 93 markersMatrix\[xidx, \"Chromosome\" \] \<- 23 94 markersMatrix\[yidx, \"Chromosome\" \] \<- 24 95 markersMatrix \$ Chromosome \<- sapply (markersMatrix \$ Chromosome, as . integer ) 96 markerID \<- apply (markersMatrix,1, function (x) paste0(x\[2\], \":\", x\[3\])) 97 print ( table ( duplicated (markerID))) 98 \#\# FALSE TRUE 99 \#\# 1831041 186 100 \# There are 186 duplicated markers 101 print ( table ( duplicated (markersMatrix \$ Probe.Name))) 102 \#\# FALSE 103 \#\# 1831227 104 \# \... with different names ! 105 \# Removed duplicates 106 markersMatrix \<- markersMatrix\[- which ( duplicated (markerID)),\] 107 \# Filter markersMatrix for common CNV 108 markerID \<- apply (markersMatrix,1, function (x) paste0(x\[2\], \":\", x\[3\])) 109 110 file \<- paste0(gdac.root, \"CNV.hg19.bypos.111213.txt\" ) 111 if ( !file. exists ( basename ( file ))) download ( file, basename ( file )) 112 commonCNV \<- readr:: read\_ tsv( basename ( file ), progress = TRUE) 113 commonID \<- apply (commonCNV,1, function (x) paste0(x\[2\], \":\", x\[3\])) 114 print ( table (commonID %in% markerID)) 115 print ( table (markerID %in% commonID)) 116 markersMatrix \_ fil \<- markersMatrix\[ ! markerID %in% commonID,\] 117 118 markers\_ obj \<-- load\_ markers( as . data . frame (markersMatrix \_ fil)) 119 nbsamples \<-- length ( get (paste0( \"query.\" ,tolower(cancer), \".nocnv\" )) \$ results\[\[1\]\] \$ cases) 120 cnv \_ obj \<-- load\_ cnv(cnvMatrix, markers \_ obj, nbsamples) 121 results \<-- runGAIA(cnv \_ obj, 122 markers \_ obj, 123 output \_file\_ name=paste0( \"GAIA \_ \" ,cancer, \" \_ flt.txt\" ), 124 aberrations = --1, 125 chromosomes = --1, 126 num \_ iterations = 10, 127 threshold = 0.25) 128 129 \# Set q--value threshold 130 threshold \<-- 0.0001 131 132 \# Plot the results 133 RecCNV \<-- t ( apply (results,1, as . numeric )) 134 colnames (RecCNV) \<-- colnames (results) 135 RecCNV \<-- cbind (RecCNV, score=0) 136 minval \<-- format ( min (RecCNV\[RecCNV\[, \"q--value\" \] != 0, \"q--value\" \]),scientific =FALSE) 137 minval \<-- substring (minval,1, nchar (minval)--1) 138 RecCNV\[RecCNV\[, \"q--value\" \]==0, \"q--value\" \] \<-- as . numeric (minval) 139 RecCNV\[, \"score\" \] \<-- sapply (RecCNV\[, \"q--value\" \], function (x) -- log10 ( as . numeric (x))) 140 RecCNV\[RecCNV\[, \"q--value\" \]== as . numeric (minval),\] 141 142 gaiaCNVplot(RecCNV,cancer,threshold) 143 save (results, RecCNV, threshold, file = paste0(cancer, \" \_ CNV \_ results.rda\" )) 144 message(paste0( \"Results saved as:\" , cancer, \" \_ CNV \_ results.rda\" )) 145 }

**Listing 10.Recurrent CNV identification in cancer with GAIA**

Recurrent amplifications and deletions were identified for both LGG ( [Figure 1a](#f1){ref-type="fig"}) and GBM ( [Figure 1b](#f1){ref-type="fig"}), and represented in chromosomal overview plots by a statistical score (-- *log* ~10~ *corrected p-value* for amplifications and *log* ~10~ *corrected p-value* for deletions). Genomic regions identified as significantly altered in copy number ( *corrected p-value* \< 10 ^--4^) were then annotated to report amplified and deleted genes potentially related with cancer.

![Recurrent CNV (\|score threshold\| = 4).](f1000research-5-11063-g0000){#f1}

***Gene annotation of recurrent CNV.*** The aberrant recurrent genomic regions in cancer, as identified by GAIA, have to be annotated to verify which genes are significantly amplified or deleted. Using biomaRt we retrieved the genomic ranges of all human genes and we compared them with significant aberrant regions to select full length genes. An example of the result is shown in [Table 1](#T1){ref-type="table"}.

###### Chromosome 20 recurrent deleted genes in LGG.

      GeneSymbol   Aberration   q-value                AberrantRegion         GeneRegion
  --- ------------ ------------ ---------------------- ---------------------- ----------------------
  1   EIF4E2P1     Del          5.74967741935484e-05   20:20540891-21005246   20:20659710-20659964
  2   LLPHP1       Del          5.74967741935484e-05   20:20540891-21005246   20:20721187-20721879
  3   RN7SL607P    Del          5.74967741935484e-05   20:20540891-21005246   20:20738433-20738731
  4   MRPS11P1     Del          5.74967741935484e-05   20:20540891-21005246   20:20854121-20854642
  5   RPL24P2      Del          5.74967741935484e-05   20:21091497-21220212   20:21114723-21115197

1 \#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\# 2 \#\# Recurrent CNV annotation \#\# 3 \#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\# 4 library (biomaRt) 5 library (GenomicRanges) 6 7 mart \<-- useMart(biomart= \"ensembl\" , dataset= \"hsapiens \_ gene \_ ensembl\" ) 8 genes \<-- getBM( attributes = c ( \"hgnc \_ symbol\" , \"chromosome \_ name\" , \"start \_ position\" , \"end \_ position\" ), 9 mart=mart) 10 genes \<-- genes\[genes\[,1\] != \"\" & genes\[,2\]%in% c (1:22, \"X\" , \"Y\" ),\] 11 xidx \<-- which (genes\[,2\]== \"X\" ) 12 yidx \<-- which (genes\[,2\]== \"Y\" ) 13 genes\[xidx, 2\] \<-- 23 14 genes\[yidx, 2\] \<-- 24 15 genes\[,2\] \<-- sapply (genes\[,2\], as . integer ) 16 genes \<-- genes\[ order (genes\[,3\]),\] 17 genes \<-- genes\[ order (genes\[,2\]),\] 18 colnames (genes) \<-- c ( \"GeneSymbol\" , \"Chr\" , \"Start\" , \"End\" ) 19 genes \_ GR \<-- makeGRangesFromDataFrame(genes,keep.extra.columns = TRUE) 20 21 for (cancer in c ( \"LGG\" , \"GBM\" )){ 22 load (paste0(cancer, \" \_ CNV \_ results.rda\" )) 23 sCNV \<-- RecCNV\[RecCNV\[, \"q--value\" \]\<=threshold, c (1:4,6)\] 24 sCNV \<-- sCNV\[ order (sCNV\[,3\]),\] 25 sCNV \<-- sCNV\[ order (sCNV\[,1\]),\] 26 colnames (sCNV) \<-- c ( \"Chr\" , \"Aberration\" , \"Start\" , \"End\" , \"q--value\" ) 27 sCNV \_ GR \<-- makeGRangesFromDataFrame(sCNV,keep.extra.columns = TRUE) 28 29 hits \<-- findOverlaps(genes \_ GR, sCNV \_ GR, type= \"within\" ) 30 sCNV \_ ann \<-- cbind (sCNV\[subjectHits(hits),\],genes\[queryHits(hits),\]) 31 AberrantRegion \<-- paste0(sCNV \_ ann\[,1\], \":\" ,sCNV \_ ann\[,3\], \"--\" ,sCNV \_ ann\[,4\]) 32 GeneRegion \<-- paste0(sCNV \_ ann\[,7\], \":\" ,sCNV \_ ann\[,8\], \"--\" ,sCNV \_ ann\[,9\]) 33 AmpDel \_ genes \<-- cbind (sCNV \_ ann\[, c (6,2,5)\],AberrantRegion,GeneRegion) 34 AmpDel \_ genes\[AmpDel \_ genes\[,2\]==0,2\] \<-- \"Del\" 35 AmpDel \_ genes\[AmpDel \_ genes\[,2\]==1,2\] \<-- \"Amp\" 36 rownames (AmpDel \_ genes) \<-- NULL 37 38 save (RecCNV, AmpDel \_ genes, file = paste0(cancer, \" \_ CNV \_ results.rda\" )) 39 }

**Listing 11. Gene annotation of recurrent CNV**

***Visualizing multiple genomic alteration events***. In order to visualize multiple genomic alteration events we recommend using OncoPrint plot which is provided by Bioconductor package [complexHeatmap](http://bioconductor.org/packages/release/bioc/html/ComplexHeatmap.html) ^[@ref-30]^. The [Listing 12](#l12){ref-type="other"} shows how to download mutation data using *GDCquery_maf* (line 4), then we filtered the genes to obtain genes with mutations found among glioma specific pathways (lines 6 -- 12). The following steps prepared the data into a matrix to fit *oncoPrint* function. We defined SNPs as blue, insertions as green and deletions as red. The upper barplot indicates the number of genetic mutation per patient, while the right barplot shows the number of genetic mutations per gene. Also, it is possible to add annotations to rows or columns. For the columns, an insertion made at the top will remove the barplot. The final result for adding the annotation to the bottom is highlighted in [Figure 2](#f2){ref-type="fig"}.

1 library (ComplexHeatmap) 2 library (TCGAbiolinks) 3 4 LGGmut \<-- GDCquery \_ Maf(tumor = \"LGG\" , pipelines = \"mutect2\" ) 5 GBMmut \<-- GDCquery \_ Maf(tumor = \"GBM\" , pipelines = \"mutect2\" ) 6 7 mut \<-- plyr:: rbind .fill(LGGmut,GBMmut) 8 9 \# Filtering mutations in gliomas 10 EA \_ pathways \<-- TCGAbiolinks:::listEA \_ pathways 11 Glioma \_ pathways \<-- EA \_ pathways\[ grep ( \"glioma\" , tolower(EA \_ pathways \$ Pathway)),\] 12 Glioma \_ signaling \<-- Glioma \_ pathways\[Glioma \_ pathways \$ Pathway == \"Glioma Signaling\" ,\] 13 Glioma \_ signaling \_ genes \<-- unlist ( strsplit ( as . character (Glioma \_ signaling \$ Molecules), \",\" )) 14 15 mut \<-- mut\[mut \$ Hugo \_ Symbol %in% Glioma \_ signaling \_ genes,\] 16 17 samples \<-- unique (mut \$ Tumor \_ Sample \_ Barcode) 18 genes \<-- unique (mut \$ Hugo \_ Symbol) 19 mat \<-- matrix (0, length (genes), length (samples)) 20 colnames ( mat ) \<-- samples 21 rownames ( mat ) \<-- genes 22 23 pb \<-- txtProgressBar( min = 0, max = nrow ( mat ), style = 3) 24 25 for (i in 1: nrow ( mat )) { 26 curGene \<-- rownames ( mat )\[i\] 27 setTxtProgressBar(pb, i) 28 for (j in 1: ncol ( mat )) { 29 curSample \<-- colnames ( mat )\[j\] 30 31 if ( length ( intersect (mut \$ Tumor \_ Sample \_ Barcode, curSample))==1){ 32 mat1 \<-- mut\[mut \$ Tumor \_ Sample \_ Barcode == curSample,\] 33 if ( length ( intersect (mat1 \$ Hugo \_ Symbol, curGene))==1){ 34 mat3 \<-- mat1\[mat1 \$ Hugo \_ Symbol == curGene,\] 35 mat \[curGene,curSample\] \<-- as . character (mat3 \$ Variant \_ Type)\[1\] 36 } 37 } 38 } 39 } 40 close (pb) 41 42 mat \[ mat ==0\] \<-- \"\" 43 colnames ( mat ) \<-- substr ( colnames ( mat ),1,12) 44 45 mat \[ is . na ( mat )\] = \"\" 46 mat \[1:3, 1:3\] 47 48 alter \_ fun = list ( 49 background = function (x, y, w, h) { 50 grid . rect (x, y, w--unit(0.5, \"mm\" ), h--unit(0.5, \"mm\" ), gp = gpar(fill = \"\#CCCCCC\" , col = NA)) 51 }, 52 SNP = function (x, y, w, h) { 53 grid . rect (x, y, w--unit(0.5, \"mm\" ), h--unit(0.5, \"mm\" ), gp = gpar(fill = \"blue\" , col = NA)) 54 }, 55 DEL = function (x, y, w, h) { 56 grid . rect (x, y, w-unit(0.5, \"mm\" ), h-unit(0.5, \"mm\" ), gp = gpar(fill = \"red\" , col = NA)) 57 }, 58 INS = function (x, y, w, h) { 59 grid . rect (x, y, w-unit(0.5, \"mm\" ), h ∗ 0.33, gp = gpar(fill = \"\#008000\" , col = NA)) 60 } 61 ) 62 63 col = c ( \"INS\" = \"\#008000\" , \"DEL\" = \"red\" , \"SNP\" = \"blue\" ) 64 65 clin.gbm \<-- GDCquery \_ clinic( \"TCGA--GBM\", \"Clinical\" ) 66 clin.lgg \<-- GDCquery \_ clinic( \"TCGA--LGG\" , \"Clinical\" ) 67 clinical \<-- plyr:: rbind .fill(clin.lgg,clin.gbm) 68 annotation \<-- clinical\[ match ( colnames ( mat ),clinical \$ bcr \_ patient \_ barcode), 69 c ( \"disease\" , \"vital \_ status\" , \"ethnicity\" )\] 70 annotation \<-- HeatmapAnnotation(annotation \_ height = rep (unit(0.3, \"cm\" ), ncol (annotation)), 71 df = annotation, 72 col = list (disease = c( \"LGG\" = \"green\" , 73 \"GBM\" = \"orange\" ), 74 vital \_status = c ( \"alive\" = \"blue\" , 75 \"dead\" = \"red\" , 76 \"not reported\" = \"grey\" ), 77 ethnicity = c ( \"hispanic or latino\" = \"purple\" , 78 \"not hispanic or latino\" = \"black\" , 79 \"not reported\" = \"grey\" )), 80 annotation \_legend\_ param = list ( title\_ gp = gpar(fontsize = 16, fontface = \"bold\" ), 81 labels\_ gp = gpar(fontsize = 16), \# size labels 82 grid\_ height = unit(8, \"mm\" ))) 83 84 pdf( \"LGG \_ GBM \_ oncoprint.pdf\" ,width = 20,height = 20) 85 p \<-- oncoPrint( mat , get \_ type = function (x) strsplit (x, \";\" )\[\[1\]\], 86 remove \_ empty \_ columns = FALSE, 87 column \_order = NULL, \# Do not sort the columns 88 alter \_ fun = alter \_ fun, col = col , 89 row_names\_ gp = gpar(fontsize = 16), \# set size for row names 90 pct \_ gp = gpar(fontsize = 16), \# set size for percentage labels 91 axis\_ gp = gpar(fontsize = 16), \# size of axis 92 column \_title = \"OncoPrint for TCGA LGG, genes in Glioma signaling\" , 93 column \_title\_ gp = gpar(fontsize = 22), 94 pct \_ digits = 2, 95 row_barplot\_ width = unit(4, \"cm\" ), \#size barplot 96 bottom \_ annotation = annotation, 97 heatmap \_legend\_ param = list ( title = \"Mutations\" , at = c ( \"DEL\" , \"INS\" , \"SNP\" ), 98 labels = c ( \"DEL\" , \"INS\" , \"SNP\" ), 99 title\_ gp = gpar(fontsize = 16, fontface = \"bold\" ), 100 labels\_ gp = gpar(fontsize = 16), \# size labels 101 grid\_ height = unit(8, \"mm\" ) 102 ) 103 ) 104 draw(p, annotation \_legend\_ side = \"bottom\" ) 105 dev . off ()

**Listing 12. Oncoprint**

![Oncoprint for LGG samples.\
Blue defines SNP, green defines insertions and red defines deletions. The upper barplot shows the number of these genetic mutations for each patient, while the right barplot shows the number of genetic mutations for each gene. The bottom bar shows the group of each sample.](f1000research-5-11063-g0001){#f2}

**Overview of genomic alterations by circos plot**

Genomic alterations in cancer, including CNV and mutations, can be represented in an effective overview plot named circos. We used circlize CRAN package to represent significant CNV (resulting from GAIA analysis) and recurrent mutations (selecting curated genetic variations retrieved from TCGA that are identified in at least two tumor samples) in LGG. Circos plot can illustrate molecular alterations genome-wide or only in one or more selected chromosomes. The [Figure 3](#f3){ref-type="fig"} shows the resulting circos plot for all chromosomes, while the [Figure 4](#f4){ref-type="fig"} shows the plot for only the chromosome 17.

1 \#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\# 2 \#\# Genomic aberration overview -- Circos plot \#\# 3 \#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\# 4 5 \# Retrieve curated mutations for selected cancer (e.g. \"LGG\") 6 library( TCGAbiolinks) 7 mut \<- GDCquery \_ Maf(tumor = \"LGG\") 8 \# Select only potentially damaging mutations 9 mut \<- mut\[mut \$ Variant \_ Classification %in% c ( \"Missense \_ Mutation\", \"Nonsense \_ Mutation\", \"Nonstop \_ Mutation\", \"Frame \_ Shift \_ Del\", \"Frame \_ Shift \_ Ins\" ),\] 10 \# Select recurrent mutations (identified in at least two samples) 11 mut.id \<- paste0(mut \$ Chromosome, \":\" ,mut \$ Start \_ position, \"--\" ,mut \$ End \_ position, \"\|\" ,mut \$ Reference \_ Allele) 12 mut \<- cbind (mut.id, mut) 13 numSamples \<- table (mut.id) 14 s.mut \<- names ( which (numSamples\>=2)) 15 \# Prepare selected mutations data for circos plot 16 s.mut \<- mut\[mut \$ mut.id %in% s.mut,\] 17 s.mut \<- s.mut\[, c ( \"Chromosome\", \"Start \_ position\", \"End \_ position\", \"Variant \_ Classification\", \"Hugo \_ Symbol\" )\] 18 s.mut \<- unique (s.mut) 19 s.mut\[,1\] \<- as . character (s.mut\[,1\]) 20 s.mut\[,4\] \<- as . character (s.mut\[,4\]) 21 s.mut\[,5\] \<- as . character (s.mut\[,5\]) 22 typeNames \<- unique (s.mut\[,4\]) 23 type \<- c (4:1) 24 names (type) \<- typeNames\[1:4\] 25 Type \<- type\[s.mut\[,4\]\] 26 s.mut \<- cbind (s.mut,Type) 27 s.mut \<- s.mut\[, c (1:3,6,4,5)\] 28 29 \# Load recurrent CNV data for selected cancer (e.g. \"LGG\") 30 load ( \"LGG \_ CNV \_ results.rda\" ) 31 \# Prepare selected sample CNV data for circos plot 32 s.cnv \<- as . data . frame (RecCNV\[RecCNV\[, \"q---value\" \]\<=10\^---4, c (1:4,6)\]) 33 s.cnv \<- s.cnv\[, c (1,3,4,2)\] 34 xidx \<- which (s.cnv \$ Chromosome==23) 35 yidx \<- which (s.cnv \$ Chromosome==24) 36 s.cnv\[xidx, \"Chromosome\" \] \<- \"X\" 37 s.cnv\[yidx, \"Chromosome\" \] \<- \"Y\" 38 Chromosome \<- sapply (s.cnv\[,1\], function (x) paste0( \"chr\" ,x)) 39 s.cnv \<- cbind (Chromosome, s.cnv\[,-1\]) 40 s.cnv\[,1\] \<- as . character (s.cnv\[,1\]) 41 s.cnv\[,4\] \<- as . character (s.cnv\[,4\]) 42 s.cnv \<- cbind (s.cnv,CNV=1) 43 colnames (s.cnv) \<- c ( \"Chromosome\", \"Start \_ position\", \"End \_ position\", \"Aberration \_ Kind\", \"CNV\" ) 44 45 \# Draw genomic circos plot 46 library (circlize) 47 pdf( \"CircosPlot.pdf\" ,width=15,height=15) 48 par (mar= c (1,1,1,1), cex=1) 49 circos.initializeWithIdeogram() 50 \# Add CNV results 51 colors \<- c ( \"forestgreen\", \"firebrick\" ) 52 names ( colors ) \<- c (0,1) 53 circos.genomicTrackPlotRegion(s.cnv , ylim = c (0,1.2), 54 panel .fun = function (region, value, \...) { 55 circos.genomicRect(region, value, ytop.column = 2, ybottom = 0, 56 col = colors \[value\[\[1\]\]\], 57 border= \"white\" ) 58 cell.xlim = get .cell.meta. data ( \"cell.xlim\" ) 59 circos. lines (cell.xlim, c (0, 0), lty = 2, col = \"\#00000040\" ) 60 }) 61 \# Add mutation results 62 colors \<- c ( \"blue\", \"green\", \"red\", \"gold\" ) 63 names ( colors ) \<- typeNames\[1:4\] 64 circos.genomicTrackPlotRegion(s.mut, ylim = c (1.2,4.2), 65 panel .fun = function (region, value, \...) { 66 circos.genomicPoints(region, value, cex = 0.8, pch = 16, col = colors \[value\[\[2\]\]\], \...) 67 }) 68 69 circos.clear() 70 71 legend (−0.2, 0.2, bty= \"n\" , y.intersp=1, c ( \"Amp\", \"Del\" ), pch=15, col = c ( \"firebrick\", \"forestgreen\" ), title = \"CNVs\", text .font=3, cex=1.2, title .adj=0) 72 legend (--0.2, 0, bty= \"n\" , y.intersp=1, names ( colors ), pch=16, col= colors, title = \"Mutations\", text .font =3, cex=1.2, title .adj=0) 73 dev . off () 74 75 \# Draw single chromosome circos plot (e.g. \"Chr 17\") 76 pdf( \"CircosPlotChr17.pdf\" ,width=18,height=13) 77 par (mar= c (1,1,1,1), cex=1.5) 78 circos. par ( \"start.degree\" = 90, canvas.xlim = c (0, 1), canvas.ylim = c (0, 1), 79 gap.degree = 270, cell.padding = c (0, 0, 0, 0), track. margin = c (0.005, 0.005)) 80 circos.initializeWithIdeogram(chromosome. index = \"chr17\" ) 81 circos. par (cell.padding = c (0, 0, 0, 0)) 82 \# Add CNV results 83 colors \<- c ( \"forestgreen\", \"firebrick\" ) 84 names ( colors ) \<- c (0,1) 85 circos.genomicTrackPlotRegion(s.cnv, ylim = c (0,1.2), 86 panel .fun = function (region, value, \...) { 87 circos.genomicRect(region, value, ytop.column = 2, ybottom = 0, 88 col = colors \[ value \[\[ 1 \]\]\], 89 border= \"white\" ) 90 cell.xlim = get .cell.meta. data ( \"cell.xlim\" ) 91 circos. lines (cell.xlim, c (0, 0), lty = 2, col = \"\#00000040\" ) 92 }) 93 94 \# Add mutation results representing single genes 95 genes.mut \<- paste0 (s.mut \$ Hugo \_ Symbol, \"--\" ,s.mut \$ Type) 96 s.mutt \<- cbind (s.mut,genes.mut) 97 n.mut \<- table (genes.mut) 98 idx \<- !duplicated (s.mutt \$ genes.mut) 99 s.mutt \<- s.mutt\[idx,\] 100 s.mutt \<- cbind (s.mutt,num=n.mut\[s.mutt \$ genes.mut\]) 101 genes.num \<- paste0(s.mutt \$ Hugo \_ Symbol, \" (\" ,s.mutt \$ num.Freq, \")\" ) 102 s.mutt \<- cbind (s.mutt\[,-- c (6:8)\],genes.num) 103 s.mutt\[,6\] \<- as . character (s.mutt\[,6\]) 104 s.mutt\[,4\] \<- s.mutt\[,4\] / 2 105 s.mutt \$ num.Freq \<- NULL 106 colors \<- c ( \"blue\", \"green\", \"red\", \"gold\" ) 107 names ( colors ) \<- typeNames\[ 1:4 \] 108 circos.genomicTrackPlotRegion(s.mutt, ylim = c (0.3,2.2), track.height = 0.05, 109 panel .fun = function (region, value, \...) { 110 circos.genomicPoints(region, value, cex = 0.8, pch = 16, col = colors \[value\[\[2\]\]\], \...) 111 }) 112 113 circos.genomicTrackPlotRegion(s.mutt, ylim = c (0, 1), track.height = 0.1, bg.border = NA) 114 i \_ track = get .cell.meta. data ( \"track.index\" ) 115 116 circos.genomicTrackPlotRegion(s.mutt, ylim = c (0,1), 117 panel .fun = function (region, value, \...) { 118 circos.genomicText(region, value, 119 y = 1, 120 labels .column = 3, 121 col = colors \[value\[\[2\]\]\], 122 facing = \"clockwise\" , adj = c (1, 0.5), 123 posTransform = posTransform. text , cex = 1.5, niceFacing = T) 124 }, track.height = 0.1, bg.border = NA) 125 126 circos.genomicPosTransformLines(s.mutt, 127 posTransform = function (region, value) 128 posTransform. text (region, 129 y = 1, 130 labels = value\[\[3\]\], 131 cex = 0.8, track. index = i \_ track+1), 132 direction = \"inside\" , track. index = i \_ track) 133 134 circos.clear() 135 136 legend (0.25, 0.2, bty= \"n\" , y.intersp=1, c ( \"Amp\", \"Del\" ), pch=15, col = c ( \"firebrick\", \"forestgreen\" ), title = \"CNVs\", text .font=3, cex=1.3, title .adj=0) 137 legend (0, 0.2, bty= \"n\" , y.intersp=1, names ( colors ), pch=16, col = colors, title = \"Mutations\", text .font =3, cex=1.3, title .adj=0) 138 dev. off ()

**Listing 13. Genomic aberration overview by circos plot**

Transcriptomic analysis
-----------------------

***Pre-Processing Data.*** The [LGG](https://gdc-portal.nci.nih.gov/legacy-archive/search/f?filters=%7B%22op%22:%22and%22,%22content%22:%5B%7B%22op%22:%22in%22,%22content%22:%7B%22field%22:%22cases.project.project_id%22,%22value%22:%5B%22TCGA-LGG%22%5D%7D%7D,%7B%22op%22:%22in%22,%22content%22:%7B%22field%22:%22files.data_category%22,%22value%22:%5B%22Gene%20expression%22%5D%7D%7D,%7B%22op%22:%22in%22,%22content%22:%7B%22field%22:%22files.data_type%22,%22value%22:%5B%22Gene%20expression%20quantification%22%5D%7D%7D,%7B%22op%22:%22in%22,%22content%22:%7B%22field%22:%22files.platform%22,%22value%22:%5B%22Illumina%20HiSeq%22%5D%7D%7D%5D%7D) and [GBM](https://gdc-portal.nci.nih.gov/legacy-archive/search/f?filters=%7B%22op%22:%22and%22,%22content%22:%5B%7B%22op%22:%22in%22,%22content%22:%7B%22field%22:%22cases.project.project_id%22,%22value%22:%5B%22TCGA-GBM%22%5D%7D%7D,%7B%22op%22:%22in%22,%22content%22:%7B%22field%22:%22files.data_category%22,%22value%22:%5B%22Gene%20expression%22%5D%7D%7D,%7B%22op%22:%22in%22,%22content%22:%7B%22field%22:%22files.data_type%22,%22value%22:%5B%22Gene%20expression%20quantification%22%5D%7D%7D,%7B%22op%22:%22in%22,%22content%22:%7B%22field%22:%22files.platform%22,%22value%22:%5B%22Illumina%20HiSeq%22%5D%7D%7D%5D%7D) data used for following transcriptomic analysis were downloaded using [TCGAbiolinks](http://bioconductor.org/packages/TCGAbiolinks.html). We downloaded only primary solid tumor (TP) samples, which resulted in 516 LGG samples and 156 GBM samples, then prepared it in two separate rse objects ( *RangedSummarizedExperiment*) saving them as an R object with a file name including both the name of the cancer and the name of the platform used for gene expression data (see [Listing 14](#l14){ref-type="other"}).

![Circos plot of recurrent CNVs and mutations in LGG.](f1000research-5-11063-g0002){#f3}

![Circos plot of chromosome 17 recurrent CNVs and mutations in LGG.](f1000research-5-11063-g0003){#f4}

1 library (TCGAbiolinks) 2 3 query \<- GDCquery(project = \"TCGA-GBM\" , 4 data . category = \"Gene expression\" , 5 data .type = \"Gene expression quantification\" , 6 platform = \"Illumina HiSeq\" , 7 file .type = \"results\" , 8 sample .type = c ( \"Primary solid Tumor\" ), 9 legacy = TRUE) 10 GDCdownload(query) 11 gbm. exp \<- GDCprepare(query, 12 save = TRUE, 13 summarizedExperiment = TRUE, 14 save .filename = \"GBMIllumina \_ HiSeq.rda\" ) 15 16 query \<- GDCquery(project = \"TCGA-LGG\" , 17 data . category = \"Gene expression\" , 18 data .type = \"Gene expression quantification\" , 19 platform = \"Illumina HiSeq\" , 20 file .type = \"results\" , 21 sample .type = c ( \"Primary solid Tumor\" ), 22 legacy = TRUE) 23 GDCdownload(query) 24 lgg. exp \<- GDCprepare(query, save = TRUE, 25 summarizedExperiment = TRUE, 26 save .filename = \"LGGIllumina \_ HiSeq.rda\" )

**Listing 14. Searching, downloading and preparing RNA-seq data with TCGAbiolinks**

To pre-process the data, first, we searched for possible outliers using the *TCGAanalyze_Preprocessing* function, which performs an Array Array Intensity correlation AAIC (lines 14--17 and 26--29 of [Listing 15](#l15){ref-type="other"}). The Array-array intensity correlation plot (AAIC) is a re-adaptation of the function correlationPlot from the R/Bioconductor [affyQCReport](https://www.bioconductor.org/packages/devel/bioc/vignettes/affyQCReport/inst/doc/affyQCReport.pdf) package ^[@ref-31]^ that shows an heat map of the array-array Spearman/Pearson rank correlation coefficients. The arrays are ordered using the phenotypic data (if available) in order to place arrays with similar samples adjacent to each other. Self-self correlations are on the diagonal and by definition have a correlation coefficient of 1.0. Data from similar tissues or treatments will tend to have higher coefficients. This plot is useful for detecting outliers, failed hybridizations, or mistracked samples.

In our example, we defined a square symmetric matrix of Pearson correlation among all samples in each cancer type (LGG or GBM). This matrix found 0 samples with low correlation (cor.cut = 0.6) that can be identified as possible outliers.

Second, using the *TCGAanalyze_Normalization* function, which encompasses the functions of the [EDASeq](http://bioconductor.org/packages/EDASeq/) package, we normalized mRNA transcripts.

The *TCGAanalyze_Normalization* performs normalization using the following functions from EDASeq: newSeqExpressionSet, withinLaneNormalization, betweenLaneNormalization, counts. The within-lane normalization procedures to adjust for GC-content effect (or other gene-level effects) on read counts ^[@ref-32]^. The between-lane normalization procedures to adjust for distributional differences between lanes (e.g., sequencing depth): global-scaling and full-quantile normalization ^[@ref-33]^.

1 library (TCGAbiolinks) 2 3 rse \<- get( load ( \"LGGIllumina \_ HiSeq.rda\" )) 4 dataClin \_ LGG \<- GDCquery \_ clinic( \"TCGA-LGG\" , \"Clinical\" ) 5 6 dataPrep \_ LGG \<- TCGAanalyze \_ Preprocessing(object = rse, 7 cor . cut = 0.6, 8 datatype = \"raw \_ count\" , 9 filename = \"LGG \_ IlluminaHiSeq \_ RNASeqV2.png\" ) 10 11 rse \<- get ( load ( \"GBMIllumina \_ HiSeq.rda\" )) 12 dataClin \_ GBM \<- GDCquery \_ clinic( \"TCGA-GBM\" , \"Clinical\" ) 13 14 dataPrep \_ GBM \<- TCGAanalyze \_ Preprocessing(object = rse, 15 cor . cut = 0.6, 16 datatype = \"raw \_ count\" , 17 filename = \"GBM \_ IlluminaHiSeq \_ RNASeqV2.png\" ) 18 19 dataNorm \<- TCGAanalyze \_ Normalization(tabDF = cbind (dataPrep \_ LGG, dataPrep \_ GBM), 20 geneInfo = geneInfo, 21 method = \"gcContent\" ) 22 23 dataFilt \<- TCGAanalyze \_ Filtering(tabDF = dataNorm, 24 method = \"quantile\" , 25 qnt. cut = 0.25) 26 27 save (dataFilt, file = paste0( \"LGG \_ GBM \_ Norm \_ IlluminaHiSeq.rda\" )) 28 29 dataFiltLGG \<- subset (dataFilt, select = substr ( colnames (dataFilt),1,12) %in% dataClin \_ LGG \$ bcr \_ patient \_ barcode) 30 dataFiltGBM \<- subset (dataFilt, select = substr ( colnames (dataFilt),1,12) %in% dataClin \_ GBM \$ bcr \_ patient \_ barcode) 31 32 dataDEGs \<- TCGAanalyze \_ DEA(mat1 = dataFiltLGG, 33 mat2 = dataFiltGBM, 34 Cond1type = \"LGG\" , 35 Cond2type = \"GBM\" , 36 fdr. cut = 0.01 , 37 logFC. cut = 1, 38 method = \"glmLRT\" )

**Listing 15. Normalizing mRNA transcripts and differential expression analysis with TCGAbiolinks**

Using *TCGAanalyze_DEA*, we identified 2,901 differentially expressed genes (DEG) (log fold change \>=1 and FDR \< 1%) between 515 LGG and 155 GBM samples.

***EA: enrichment analysis.*** In order to understand the underlying biological process of DEGs we performed an enrichment analysis using *TCGAanalyze_EA_complete* function (see [Listing 16](#l16){ref-type="other"}).

1 ansEA \<-- TCGAanalyze \_ EAcomplete(TFname= \"DEA genes LGG Vs GBM\" , RegulonList = rownames (dataDEGs)) 2 3 TCGAvisualize \_ EAbarplot(tf = rownames (ansEA \$ ResBP), 4 GOBPTab = ansEA \$ ResBP, GOCCTab = ansEA \$ ResCC, 5 GOMFTab = ansEA \$ ResMF, PathTab = ansEA \$ ResPat, 6 nRGTab = rownames (dataDEGs), 7 nBar = 20)

**Listing 16. Enrichment analysis**

*TCGAanalyze_EAbarplot* outputs a bar chart as shown in [Figure 5](#f5){ref-type="fig"} with the number of genes for the main categories of three ontologies (i.e., GO:biological process, GO:cellular component, and GO:molecular function).

![The plot shows canonical pathways significantly over-represented (enriched) by the DEGs (differentially expressed genes) with the number of genes for the main categories of three ontologies (GO:biological process, GO:cellular component, and GO:molecular function, respectively).\
The most statistically significant canonical pathways identified in DEGs are listed according to their p-value corrected FDR (-Log10) (colored bars) and the ratio of listed genes found in each pathway over the total number of genes in that pathway (ratio, red line).](f1000research-5-11063-g0004){#f5}

The [Figure 5](#f5){ref-type="fig"} shows canonical pathways significantly over-represented (enriched) by the DEGs. The most statistically significant canonical pathways identified in the DEGs are ranked according to their p-value corrected FDR (-Log10) (colored bars) and the ratio of list genes found in each pathway over the total number of genes in that pathway (ratio, red line).

***PEA: Pathways enrichment analysis.*** To verify if the genes found have a specific role in a pathway, the Bioconductor package [pathview](http://bioconductor.org/packages/pathview/) ^[@ref-34]^ can be used. [Listing 17](#l17){ref-type="other"} shows an example how to use it. It can receive, for example, a named vector of gene with the expression level, the pathway.id which can be found in [KEGG database](http://www.genome.jp/kegg/pathway.html), the species ('hsa' for Homo sapiens) and the limits for the gene expression (see [Figure 6](#f6){ref-type="fig"}).

![Pathways enrichment analysis : glioma pathway.\
Red defines genes that are up-regulated and green defines genes that are down-regulated.](f1000research-5-11063-g0005){#f6}

1 GenelistComplete \<-- rownames (assay(rse,1)) 2 3 \# DEGs TopTable 4 dataDEGsFiltLevel \<-- TCGAanalyze \_ LevelTab(dataDEGs, \"LGG\" , \"GBM\" , 5 dataFilt\[, colnames (dataFiltLGG)\], 6 dataFilt\[, colnames (dataFiltGBM)\]) 7 8 dataDEGsFiltLevel \$ GeneID \<-- 0 9 10 \# Converting Gene symbol to geneID 11 library (clusterProfiler) 12 eg = as . data . frame ( bitr(dataDEGsFiltLevel \$ mRNA, 13 fromType= \"SYMBOL\" , 14 toType= \"ENTREZID\" , 15 OrgDb= \"org.Hs.eg.db\" )) 16 eg \<-- eg\[ !duplicated (eg \$ SYMBOL),\] 17 18 dataDEGsFiltLevel \<-- dataDEGsFiltLevel\[dataDEGsFiltLevel \$ mRNA %in% eg \$ SYMBOL,\] 19 20 dataDEGsFiltLevel \<-- dataDEGsFiltLevel\[ order (dataDEGsFiltLevel \$ mRNA,decreasing=FALSE),\] 21 eg \<-- eg\[ order (eg \$ SYMBOL,decreasing=FALSE),\] 22 23 \# table(eg \$ SYMBOL == dataDEGsFiltLevel \$ mRNA) should be TRUE 24 all (eg \$ SYMBOL == dataDEGsFiltLevel \$ mRNA) 25 dataDEGsFiltLevel \$ GeneID \<-- eg \$ ENTREZID 26 27 dataDEGsFiltLevel \_sub \<-- subset (dataDEGsFiltLevel, select = c ( \"GeneID\", \"logFC\" )) 28 genelistDEGs \<-- as . numeric (dataDEGsFiltLevel \_sub\$ logFC) 29 names (genelistDEGs) \<-- dataDEGsFiltLevel \_sub\$ GeneID 30 31 require ( \"pathview\" ) 32 \# pathway.id: hsa05214 is the glioma pathway 33 \# limit: sets the limit for gene expression legend and color 34 hsa05214 \<-- pathview(gene. data = genelistDEGs, 35 pathway.id = \"hsa05214\" , 36 species = \"hsa\" , 37 limit = list (gene= as . integer ( max ( abs (genelistDEGs)))))

**Listing 17. Pathways enrichment analysis with [pathview](http://bioconductor.org/packages/pathview/) package**

The red genes are up-regulated and the green genes are down-regulated in the LGG samples compared to GBM.

***Inference of gene regulatory networks.*** Starting with the set of differentially expressed genes, we infer gene regulatory networks using the following state-of-the art inference algorithms: ARACNE ^[@ref-35]^, CLR ^[@ref-36]^, MRNET ^[@ref-37]^ and C3NET ^[@ref-38]^. These methods are based on mutual inference and use different heuristics to infer the edges in the network. These methods have been made available via Bioconductor/CRAN packages ( [MINET](http://bioconductor.org/packages/minet/) ^[@ref-39]^ and [c3net](https://cran.r-project.org/web/packages/c3net/index.html) ^[@ref-38]^, respectively).

Many gene regulatory interactions have been experimentally validated and published. These 'known' interactions can be accessed using different tools and databases such as BioGrid ^[@ref-40]^ or GeneMANIA ^[@ref-41]^. However, this knowledge is far from complete and in most cases only contains a small subset of the real interactome. The quality assessment of the inferred networks can be carried out by comparing the inferred interactions to those that have been validated. This comparison results in a confusion matrix as presented in [Table 2](#T2){ref-type="table"}.

###### Confusion matrix, comparing inferred network to network of validated interactions.

                 validated   not validated/non-existing
  -------------- ----------- ----------------------------
  inferred       TP          FP
  not inferred   FN          TN

Different quality measures can then be computed such as the false positive rate $$fpr = \frac{FP}{FP + TN},$$ the true positive rate (also called recall) $$tpr = \frac{TP}{TP + FN}$$ and the precision $$p = \frac{TP}{TP + FP}.$$

The performance of an algorithm can then be summarized using ROC (false positive rate versus true positive rate) or PR (precision versus recall) curves.

A weakness of this type of comparison is that an edge that is not present in the set of known interactions can either mean that an experimental validation has been tried and did not show any regulatory mechanism or (more likely) has not yet been attempted.

In the following, we ran the nce on i) the 2,901 differentially expressed genes identified in Section "Transcriptomic analysis".

**Retrieving known interactions**

As previously stated, different sources for protein-protein interactions are available (e.g. [I2D](http://ophid.utoronto.ca/ophidv2.204/), [BioGrid database](https://thebiogrid.org/) ). In this example, we obtained a set of known interactions from the [BioGrid database](https://thebiogrid.org/), but the users can chose their preferred database.

1 get .adjacency.biogrid \<-- function (tmp.biogrid, names .genes = NULL){ 2 3 if ( is . null ( names .genes)){ 4 names .genes \<-- sort ( union ( unique (tmp.biogrid\[, \"Official.Symbol.Interactor.A\" \]), 5 unique (tmp.biogrid\[, \"Official.Symbol.Interactor.B\" \]))) 6 ind \<-- seq (1, nrow (tmp.biogrid)) 7 } else { 8 ind.A \<-- which (tmp.biogrid\[, \"Official.Symbol.Interactor.A\" \]%in% names .genes) 9 ind.B \<-- which (tmp.biogrid\[, \"Official.Symbol.Interactor.B\" \]%in% names .genes) 10 11 ind \<-- intersect (ind.A, ind.B) 12 } 13 14 mat .biogrid \<-- matrix (0, nrow = length ( names .genes), ncol = length ( names .genes), dimnames = list ( names . genes, names .genes)) 15 16 for (i in ind){ 17 mat .biogrid\[tmp.biogrid\[i, \"Official.Symbol.Interactor.A\" \], tmp.biogrid\[i, \"Official.Symbol. Interactor.B\" \]\] \<-- mat .biogrid\[tmp.biogrid\[i, \"Official.Symbol.Interactor.B\" \], tmp.biogrid\[i, \" Official.Symbol.Interactor.A\" \]\] \<-- 1 18 } 19 diag ( mat .biogrid) \<-- 0 20 21 return ( mat .biogrid) 22 }

There are 3,941 unique interactions between the 2,901 differentially expressed genes.

**Using differentially expressed genes from TCGAbiolinks workflow**

We start this analysis by inferring two gene regulatory networks (the corresponding number of edges are presented in [Table 3](#T3){ref-type="table"}) for the GBM data set and one gene set for the LGG data.

###### Number of edges in the inferred gene regulatory networks; first two lines: networks inferred using 2,901 differentially expressed genes.

  gene set   inference algorithm   aracne   c3net       clr         mrnet
  ---------- --------------------- -------- ----------- ----------- -----------
  DE         GBM                   5,903    2,678       1,718,328   1,682,334
  LGG        4,443                 2,684    1,939,142   1,859,121   

1 \#\#\# plot details (colors & symbols) 2 mycols \<--c ( \'\#e41a1c\' , \'\#377eb8\' , \'\#4daf4a\' , \'\#984ea3\' , \'\#ff7f00\' , \'\#ffff33\' , \'\#a65628\' ) 3 4 \#\#\# load network inference libraries 5 library (minet) 6 library (c3net) 7 8 \#\#\# deferentially identified genes using TCGAbiolinks 9 names .genes. de \<-- rownames (dataDEGs) 10 11 \#\#\# read biogrid info 12 library (downloader) 13 file \<-- \"http: // thebiogrid.org / downloads / archives / Release%20Archive / BIOGRID--3.4.133 / BIOGRID--ALL --3.4.133.tab2.zip\" 14 download ( file , basename ( file )) 15 unzip( basename ( file ),junkpaths =T) 16 tmp.biogrid \<-- read . csv ( gsub ( \"zip\" , \"txt\" , basename ( file )), header=TRUE, sep= \"\\t\" , stringsAsFactors= FALSE) 17 18 net.biogrid. de \<-- get .adjacency.biogrid(tmp.biogrid, names .genes. de ) 19 20 for (cancertype in c ( \"LGG\" , \"GBM\" )) { 21 22 if (cancertype == \"GBM\" ){ 23 mydata \<-- dataFiltGBM\[ names .genes. de , \] 24 } else if (cancertype == \"LGG\" ){ 25 mydata \<-- dataFiltLGG\[ names .genes. de , \] 26 } 27 \#\#\# infer networks 28 net.aracne \<-- minet( t (mydata), method = \"aracne\" ) 29 net.mrnet \<-- minet( t (mydata)) 30 net.clr \<-- minet( t (mydata), method = \"clr\" ) 31 net.c3net \<-- c3net(mydata) 32 33 \#\#\# validate compared to biogrid network 34 tmp.val \<-- list (validate(net.aracne, net.biogrid. de ), validate(net.mrnet, net.biogrid. de ), 35 validate(net.clr, net.biogrid. de ), validate(net.c3net, net.biogrid. de )) 36 37 \#\#\# plot roc and compute auc for the different networks 38 dev1 \<-- show .roc(tmp.val\[\[1\]\],cex=0.3, col =mycols\[1\],type= \"l\" ) 39 res.auc \<-- auc.roc(tmp.val\[\[1\]\]) 40 for ( count in 2: length (tmp.val)){ 41 show .roc(tmp.val\[\[ count \]\],device=dev1,cex=0.3, col =mycols\[ count \],type= \"l\" ) 42 res.auc \<-- c (res.auc, auc.roc(tmp.val\[\[ count \]\])) 43 } 44 45 legend ( \"bottomright\" , legend = paste ( c ( \"aracne\" , \"mrnet\" , \"clr\" , \"c3net\" ), signif (res.auc,4), sep= \": \" ), 46 col =mycols\[1: length (tmp.val)\],lty=1, bty= \"n\" ) 47 dev .copy2pdf(width=8,height=8,device = dev1, file = paste0( \"roc \_ biogrid \_ \" ,cancertype, \".pdf\" )) 48 save (net.aracne, net.mrnet, net.clr, net.c3net, file =paste0( \"nets \_ \" ,cancertype, \".RData\" )) 49 50 }

In [Figure 7](#f7){ref-type="fig"}, the obtained ROC curve and the corresponding area under curve (AUC) are presented. It can be observed that CLR and MRNET perform best when comparing the inferred network with known interactions from the BioGrid database.

![ROC with corresponding AUC for inferred GBM networks compared to BioGrid interactions using 2901 genes.](f1000research-5-11063-g0006){#f7}

Epigenetic analysis
-------------------

The DNA methylation is an important component in numerous cellular processes, such as embryonic development, genomic imprinting, X-chromosome inactivation, and preservation of chromosome stability ^[@ref-42]^.

In mammals DNA methylation is found sparsely but globally, distributed in definite CpG sequences throughout the entire genome; however, there is an exception. CpG islands (CGIs) which are short interspersed DNA sequences that are enriched for GC. These islands are normally found in sites of transcription initiation and their methylation can lead to gene silencing ^[@ref-43]^.

Thus, the investigation of the DNA methylation is crucial to understanding regulatory gene networks in cancer as the DNA methylation represses transcription ^[@ref-44]^. Therefore, the DMR (Differentially Methylation Region) detection can help us investigate regulatory gene networks.

This section describes the analysis of DNA methylation using the Bioconductor package [TCGAbiolinks](http://bioconductor.org/packages/TCGAbiolinks/) ^[@ref-8]^. For this analysis, and due to the time required to perform it, we selected only 10 LGG samples and 10 GBM samples that have both DNA methylation data from Infinium HumanMethylation450 and gene expression from Illumina HiSeq 2000 RNA Sequencing Version 2 analysis (lines 1--56 of the [Listing 18](#l18){ref-type="other"} describes how to make the data acquisition). We started by checking the mean DNA methylation of different groups of samples, then performed a DMR in which we search for regions of possible biological significance, (e.g., regions that are methylated in one group and unmethylated in the other). After finding these regions, they can be visualized using heatmaps.

***Visualizing the mean DNA methylation of each patient.*** It should be highlighted that some pre-processing of the DNA methylation data was done. The DNA methylation data from the 450k platform has three types of probes cg (CpG loci), ch (non-CpG loci) and rs (SNP assay). The last type of probe can be used for sample identification and tracking and should be excluded for differential methylation analysis according to the [ilumina manual](https://support.illumina.com/content/dam/illumina-support/documents/myillumina/90666eaa-0c66-48b4-8199-3be99b2b3ef9/genomestudio_methylation_v1.8_user_guide_11319130_b.pdf). Therefore, the rs probes were removed (see [Listing 18](#l17){ref-type="other"} lines 68). Also, probes in chromosomes X, Y were removed to eliminate potential artifacts originating from the presence of a different proportion of males and females ^[@ref-45]^. The last pre-processing steps were to remove probes with at least one NA value (see [Listing 18](#l18){ref-type="other"} lines 65).

After this pre-processing step and using the function *TCGAvisualize_meanMethylation* function, we can look at the mean DNA methylation of each patient in each group. It receives as argument a *summarizedExperiment* object with the DNA methylation data, and the arguments *groupCol* and *subgroupCol* which should be two columns from the sample information matrix of the *summarizedExperiment* object (accessed by the *colData* function) (see [Listing 18](#l18){ref-type="other"} lines 70--74).

1 \#-------------------------------------------------------- 2 \# Obtaining DNA methylation 3 \#-------------------------------------------------------- 4 library (TCGAbiolinks) 5 library (stringr) 6 \# Samples 7 matched \_ met \_exp \<-- function (project, n = NULL){ 8 \# get primary solid tumor samples: DNA methylation 9 message( \"Download DNA methylation information\" ) 10 met450k \<- GDCquery(project = project, 11 data . category = \"DNA methylation\" , 12 platform = \"Illumina Human Methylation 450\" , 13 legacy = TRUE, 14 sample .type = c ( \"Primary solid Tumor\" )) 15 met450k.tp \<- met450k \$ results\[\[1\]\] \$ cases 16 17 \# get primary solid tumor samples: RNAseq 18 message( \"Download gene expression information\" ) 19 exp \<- GDCquery(project = project, 20 data . category = \"Gene expression\" , 21 data .type = \"Gene expression quantification\" , 22 platform = \"Illumina HiSeq\" , 23 file .type = \"results\" , 24 sample .type = c ( \"Primary solid Tumor\" ), 25 legacy = TRUE) 26 exp .tp \<- exp\$ results\[\[1\]\] \$ cases 27 print ( exp .tp\[1:10\]) 28 \# Get patients with samples in both platforms 29  patients \<-- unique ( substr ( exp .tp,1,15)\[ substr ( exp .tp,1,12) %in% substr (met450k.tp,1,12)\]) 30 if ( !is . null (n)) patients \<-- patients\[1:n\] \# get only n samples 31 return (patients) 32 } 33 lgg.samples \<-- matched \_ met \_exp ( \"TCGA--LGG\" , n = 10) 34 gbm.samples \<-- matched \_ met \_exp ( \"TCGA--GBM\" , n = 10) 35 samples \<-- c (lgg.samples,gbm.samples) 36 37 38 \#---------------------------------------------------------------------- 39 \# 1 -- Methylation 40 \# -------------------------------------------------------------------- 41 \# For methylation it is quicker in this case to download the tar.gz file 42 \# and get the samples we want instead of downloading files by files 43 query.lgg \<- GDCquery(project = \"TCGA-LGG\" , 44 data . category = \"DNA methylation\" , 45 platform = \"Illumina Human Methylation 450\" , 46 legacy = TRUE, barcode = lgg.samples) 47 GDCdownload(query.lgg) 48 met.lgg \<- GDCprepare(query.lgg, save = FALSE) 49 50 query.gbm \<- GDCquery(project = \"TCGA-GBM\" , 51 data . category = \"DNA methylation\" , 52 platform = \"Illumina Human Methylation 450\" , 53 legacy = TRUE, barcode = gbm.samples) 54 GDCdownload(query.gbm) 55 met.gbm \<- GDCprepare(query.gbm, save = FALSE) 56 met \<- SummarizedExperiment:: cbind (met.lgg, met.gbm) 57 58 \#-------------------------------------------------------- 59 \# Mean methylation 60 \#-------------------------------------------------------- 61 \# Plot a barplot for the groups in the disease column in the 62 \# summarizedExperiment object 63 64 \# remove probes with NA (similar to na.omit) 65 met \<-- subset (met, subset = (rowSums( is . na (assay(met))) == 0)) 66 67 \# remove probes in chromossomes X, Y and NA 68 met \<-- subset (met, subset = !as . character (seqnames(met)) %in% c ( \"chrNA\" , \"chrX\" , \"chrY\" )) 69 70 TCGAvisualize \_ meanMethylation(met, 71 groupCol = \"disease \_ type\" , 72 group. legend = \"Groups\" , 73 filename = \"mean \_ lgg \_ gbm.png\" , 74 print .pvalue = TRUE)

**Listing 18. Visualizing the DNA mean methylation of groups**

[Figure 8](#f8){ref-type="fig"} illustrates a mean DNA methylation plot for each sample in the GBM group (140 samples) and a mean DNA methylation for each sample in the LGG group. Genome-wide view of the data highlights a difference between the groups of tumors (p-value = 6.1x10 ^−06^).

***Searching for differentially methylated CpG sites.*** The next step is to define differentially methylated CpG sites between the two groups. This can be done using the *TCGAanalyze_DMR* function (see [Listing 19](#l19){ref-type="other"}). The DNA methylation data (level 3) is presented in the form of beta-values that uses a scale ranging from 0.0 (probes completely unmethylated) up to 1.0 (probes completely methylated).

To find these differentially methylated CpG sites, first, the function calculates the difference between the mean DNA methylation (mean of the beta-values) of each group for each probe. Second, it test for differential expression between two groups using the Wilcoxon test adjusting by the Benjamini-Hochberg method. Arguments of TCGAanalyze_DMR was set to require a minimum absolute beta-values difference of 0.25 and an adjusted p-value of less than 10 ^−2^.

![Boxplot of mean DNA methylation of each sample (black dots).](f1000research-5-11063-g0007){#f8}

After these tests, a volcano plot (x-axis: difference of mean DNA methylation, y-axis: statistical significance) is created to help users identify the differentially methylated CpG sites and return the object with the results in the rowRanges. [Figure 9](#f9){ref-type="fig"} shows the volcano plot produced by [Listing 19](#l19){ref-type="other"}. This plot aids the user in selecting relevant thresholds, as we search for candidate biological DMRs.

1 \# Becareful ! Depending on the number of probes and samples this function might take some days. 2 \# To make this example faster we used only the chromosome 9 3 \# This should take some minutes 4 met.chr9 \<-- subset (met, subset = as . character (seqnames(met)) %in% c ( \"chr9\" )) 5 6 met.chr9 \<-- TCGAanalyze \_ DMR(met.chr9, 7 groupCol = \"disease \_ type\" , \# a column in the colData matrix 8 group1 = \"Glioblastoma Multiforme\" , \# a type of the disease type column 9 group2= \"Brain Lower Grade Glioma\" , \# a type of the disease column 10 p. cut = 10\^--2, 11 diffmean. cut = 0.25, 12 legend = \"State\" , 13 plot .filename = \"LGG \_ GBM \_ metvolcano.png\" , 14 cores = 1 \# if set to 1 there will be a progress bar 15 )

**Listing 19. Finding differentially methylated CpG sites**

![Volcano plot: searching for differentially methylated CpG sites (x-axis:difference of mean DNA methylation, y-axis: statistical significance).](f1000research-5-11063-g0008){#f9}

To visualize the level of DNA methylation of these probes across all samples, we use heatmaps that can be generate by the bioconductor package [complexHeatmap](http://bioconductor.org/packages/ComplexHeatmap/) ^[@ref-30]^. To create a heatmap using the [complexHeatmap](http://bioconductor.org/packages/ComplexHeatmap/) package, the user should provide at least one matrix with the DNA methylation levels. Also, annotation layers can be added and placed at the bottom, top, left side and right side of the heatmap to provide additional metadata description. The [Listing 20](#l20){ref-type="other"} shows the code to produce the heatmap of a DNA methylation datum ( [Figure 10](#f10){ref-type="fig"}).

1 \#---------------------------------------------------- 2 \# DNA methylation heatmap 3 \#-------------------------------------------------- 4 library (ComplexHeatmap) 5 6 clin.gbm \<-- GDCquery \_ clinic( \"TCGA-GBM\" , \"Clinical\" ) 7 clin.lgg \<-- GDCquery \_ clinic( \"TCGA-LGG\" , \"Clinical\" ) 8 clinical \<-- plyr:: rbind .fill(clin.lgg, clin.gbm) 9 10 \# get the probes that are Hypermethylated or Hypomethylated 11 \# met is the same object of the section \'DNA methylation analysis\' 12 sig.met \<-- met.chr9\[values(met.chr9)\[, \"status.Glioblastoma.Multiforme.Brain.Lower.Grade.Glioma\" \] %in% c ( \"Hypermethylated\" , \"Hypomethylated\" ),\] 13 14 \# To speed up the example, we will select no more than 100 probes 15 nb.probes \<- ifelse ( nrow (sig.met) \> 100, 100, nrow (sig.met)) \# If there is more than 100 get 100 16 sig.met.100 \<-- sig.met\[1:nb.probes,\] 17 18 \# top annotation, which sampples are LGG and GBM 19 \# We will add clinical data as annotation of the samples 20 \# we will sort the clinical data to have the same order of the DNA methylation matrix 21 clinical. order \<-- clinical\[ match ( substr ( colnames (sig.met.100),1,12),clinical \$ bcr \_ patient \_ barcode),\] 22 ta = HeatmapAnnotation( df = clinical. order \[, c ( \"disease\" , \"gender\" , \"vital \_ status\" , \"race\" )\], 23 col = list (disease = c ( \"LGG\" = \"grey\" , \"GBM\" = \"black\" ), 24 gender = c ( \"male\" = \"blue\" , \"female\" = \"pink\" ))) 25 26 \# row annotation: add the status for LGG in relation to GBM 27 \# For exmaple: status.gbm.lgg Hypomethyated means that the 28 \# mean DNA methylation of probes for lgg are hypomethylated 29 \# compared to GBM ones. 30 ra = rowAnnotation( df = values(sig.met.100)\[ \"status.Glioblastoma.Multiforme.Brain.Lower.Grade.Glioma\" \], 31 col = list ( \"status.Glioblastoma.Multiforme.Brain.Lower.Grade.Glioma\" = c ( \"Hypomethylated\" = \"orange\" , 32 \"Hypermethylated\" = \"darkgreen\" )), 33 width = unit(1, \"cm\" )) 34 35 heatmap \<-- Heatmap(assay(sig.met.100), 36 name = \"DNA methylation\" , 37 col = matlab::jet. colors (200), 38 show_row_names = F, 39 cluster \_ rows = T, 40 cluster \_ columns = F, 41 show\_ column \_names = F, 42 bottom \_ annotation = ta, 43 column \_ title = \"DNA methylation\" ) 44 \# Save to pdf 45 pdf( \"heatmap.pdf\" ,width = 10, height = 8) 46 draw(heatmap, annotation \_legend\_ side = \"bottom\" ) 47 dev . off ()

**Listing 20. Creating heatmaps for DNA methylation using ComplexHeatmap**

![Heatmap of DNA methylation in probes.\
Rows are probes and columns are samples (patients). The DNA methylation values range from 0.0 (completely DNA unmethylated, blue) to 1.0 (completely DNA methylated, red). The groups of each sample were annotated in the top bar and the DNA methylation status for each probe was annotated in the right bar.](f1000research-5-11063-g0009){#f10}

***Motif analysis.*** Motif discovery is the attempt to extract small sequence signals hidden within largely non-functional intergenic sequences. These small sequence nucleotide signals (6--15 bp) might have a biological significance as they can be used to control the expression of genes. These sequences are called Regulatory motifs. The bioconductor package [rGADEM](http://bioconductor.org/packages/rGADEM/) ^[@ref-46],\ [@ref-47]^ provides an efficient *de novo* motif discovery algorithm for large-scale genomic sequence data.

The user may be interested in looking for unique signatures in the regions defined by 'differentially methylated' to identify candidate transcription factors that could bind to these elements affected by the accumulation or absence of DNA methylation. For this analysis we use a sequence of 100 bases before and after the probe location (See lines 6--8 in the [Listing 21](#l21){ref-type="other"}). An object will be returned which contains all relevant information about your motif analysis (i.e., sequence consensus, pwm, chromosome, p-value, etc).

Using bioconductor package [motifStack](http://bioconductor.org/packages/motifStack/) ^[@ref-48]^ it is possible to generate a graphic representation of multiple motifs with different similarity scores (see [Figure 11](#f11){ref-type="fig"}).

1 library (rGADEM) 2 library (BSgenome.Hsapiens.UCSC.hg19) 3 library (motifStack) 4 5 probes \<-- rowRanges(met.chr9)\[values(met.chr9)\[, \"status.Glioblastoma.Multiforme.Brain.Lower.Grade.        Glioma\" \]%in% c ( \"Hypermethylated\" , \"Hypomethylated\" ),\] 6 \# Get hypo / hyper methylated probes and make a 200bp window 7 \# surrounding each probe. 8 sequence \<-- RangedData(space= as . character (probes\@seqnames), 9 IRanges( start =probes\@ranges\@start -- 100, 10 end =probes\@ranges\@start + 100), strand= \" ∗ \" ) 11 \#look for motifs 12 gadem \<-- GADEM( sequence , verbose=FALSE, genome=Hsapiens) 13 14 \# How many motifs were found? 15 length (gadem\@motifList) 16 17 \# get the number of occurences 18 nOccurrences(gadem) 19 20 \# view all sequences consensus 21 consensus(gadem) 22 23 \# print motif 24 pwm \<-- getPWM(gadem) 25 pfm \<-- new ( \"pfm\" , mat =pwm\[\[1\]\],name= \"Novel Site 1\" ) 26 plotMotifLogo(pfm) 27 28 \# Number of instances of motif 1? 29 length (gadem\@motifList\[\[1\]\]\@alignList)

**Listing 21. rGADEM: *de novo* motif discovery**

![Motif logos found during *de-novo* motif analysis.](f1000research-5-11063-g0010){#f11}

After [rGADEM](http://bioconductor.org/packages/rGADEM/) returns it's results, the user can use [MotIV](http://bioconductor.org/packages/MotIV/) package ^[@ref-49]--\ [@ref-52]^ to start the motif matching analysis (line 4 of [Listing 22](#l22){ref-type="other"}). The result is shown in [Figure 12](#f12){ref-type="fig"}.

1 library (MotIV) 2 3 analysis.jaspar \<-- motifMatch(pwm) 4 summary (analysis.jaspar) 5 plot (analysis.jaspar, ncol =1, top=5, rev =FALSE, 6 main= \"\" , bysim=TRUE, cex=0.3) 7 8 \# visualize the quality of the results around the alignments 9 \# E--value give an estimation of the match. 10 alignment \<-- viewAlignments(analysis.jaspar ) 11 print (alignment\[\[1\]\])

**Listing 22. MotIV: motifs matches analysis.**

![Identified transcription factors: the sequence logo, the name of the motif match and the p-value of the alignment.](f1000research-5-11063-g0011){#f12}

Integrative (Epigenomic & Transcriptomic) analysis
--------------------------------------------------

Recent studies have shown that providing a deep integrative analysis can aid researchers in identifying and extracting biological insight from high through put data ^[@ref-42],\ [@ref-53],\ [@ref-54]^. In this section, we will introduce a Bioconductor package called [ELMER](http://bioconductor.org/packages/ELMER/) to identify regulatory enhancers using gene expression + DNA methylation data + motif analysis. In addition, we show how to integrate the results from the previous sections with important epigenomic data derived from both the [ENCODE](https://www.encodeproject.org/) and [Roadmap](http://www.roadmapepigenomics.org/).

***Integration of DNA methylation & gene expression data.*** After finding differentially methylated CpG sites, one might ask whether nearby genes also undergo a change in expression either an increase or a decrease. DNA methylation at promoters of genes has been shown to be associated with silencing of the respective gene. The starburst plot is proposed to combine information from two volcano plots and is applicable for studies of DNA methylation and gene expression ^[@ref-55]^. Even though, being desirable that both gene expression and DNA methylation data are from the same samples, the starburst plot can be applied as a meta-analysis tool, combining data from different samples ^[@ref-56]^. We used the *TCGAvisualize_starburst* function to create a starburst plot. The *log* ~10~ (FDR-corrected P value) for DNA methylation is plotted on the x axis, and for gene expression on the y axis, for each gene. The horizontal black dashed line shows the FDR-adjusted P value of 10 ^--2^ for the expression data and the vertical ones shows the FDR-adjusted P value of 10 ^--2^ for the DNA methylation data. The starburst plot for the [Listing 23](#l23){ref-type="other"} is shown in [Figure 13](#f13){ref-type="fig"}. While the argument met.p.cut and exp.p.cut controls the black dashed lines, the arguments *diffmean.cut* and *logFC.cut* will be used to highlight the genes that respects these parameters (circled genes in [Figure 13](#f13){ref-type="fig"}). For the example below we set higher p.cuts trying to get the most significant list of pair gene/probes. But for the next sections we will use *exp.p.cut = 0.01* and *logFC.cut = 1* as the previous sections.

1 \#\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-- Starburst plot \-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-- 2 starburst \<-- TCGAvisualize \_ starburst(met.chr9, \# DNA methylation with results 3 dataDEGs, \# DEG results 4 group1 = \"Glioblastoma Multiforme\" , 5 group2 = \"Brain Lower Grade Glioma\" , 6 filename = \"starburst.png\" , 7 met.p. cut = 10\^−2, 8 exp .p. cut = 10\^−2, 9 diffmean. cut = 0.25, 10 logFC. cut = 1,width = 15,height = 10, 11 names = TRUE)

**Listing 23. Starburst plot for comparison of DNA methylation and gene expression**

![Starburst plot: x-axis is the log10 of the correct P-value for DNA methylation and the y-axis is the log10 of the correct P-value for the expression data.\
The starburst plot highlights nine distinct quadrants. Highlighted genes might have the potential for activation due to epigenetic alterations.](f1000research-5-11063-g0012){#f13}

***ChIP-seq analysis.*** ChIP-seq is used primarily to determine how transcription factors and other chromatin-associated proteins influence phenotype-affecting mechanisms. Determining how proteins interact with DNA to regulate gene expression is essential for fully understanding many biological processes and disease states. The aim is to explore significant overlap datasets for inferring co-regulation or transcription factor complex for further investigation. A summary of the association of each histone mark is shown in [Table 4](#T4){ref-type="table"}. Besides, ChIP-seq data exists in the ROADMAP database and can be obtained through the [AnnotationHub](http://bioconductor.org/packages/AnnotationHub/) package ^[@ref-57]^ or from [Roadmap web portal](http://egg2.wustl.edu/roadmap/web_portal/processed_data.html). The [Table 5](#T5){ref-type="table"} shows the description for all the Roadmap files that are available through AnnotationHub. After obtaining the ChIP-seq data, we can then identify overlapping regions with the regions identified in the starburst plot. The narrowPeak files are the ones selected for this step.

###### Histone marks that define genomic elements.

  -------------------------------------------------------------------------------------------
  Histone marks                                    Role
  ------------------------------------------------ ------------------------------------------
  Histone H3 lysine 4 trimethylation (H3K4me3)     Promoter regions ^[@ref-58],\ [@ref-59]^

  Histone H3 lysine 4 monomethylation (H3K4me1)    Enhancer regions ^[@ref-58]^

  Histone H3 lysine 36 trimethylation (H3K36me3)   Transcribed regions

  Histone H3 lysine 27 trimethylation (H3K27me3)   Polycomb repression ^[@ref-60]^

  Histone H3 lysine 9 trimethylation (H3K9me3)     Heterochromatin regions ^[@ref-61]^

  Histone H3 acetylated at lysine 27 (H3K27ac)     Increase activation of genomic\
                                                   elements ^[@ref-62]--\ [@ref-64]^

  Histone H3 lysine 9 acetylation (H3K9ac)         Transcriptional activation ^[@ref-65]^
  -------------------------------------------------------------------------------------------

###### ChIP-seq data file types available in AnnotationHub.

  ------------------------------------------------------------------------------------------
  File                                Description
  ----------------------------------- ------------------------------------------------------
  fc.signal.bigwig                    Bigwig File containing fold enrichment signal tracks

  pval.signal.bigwig                  Bigwig File containing -log10(p-value) signal tracks

  hotspot.fdr0.01.broad.bed.gz        Broad domains on enrichment for DNase-seq for\
                                      consolidated epigenomes

  hotspot.broad.bed.gz                Broad domains on enrichment for DNase-seq for\
                                      consolidated epigenomes

  broadPeak.gz                        Broad ChIP-seq peaks for consolidated epigenomes

  gappedPeak.gz                       Gapped ChIP-seq peaks for consolidated epigenomes

  narrowPeak.gz                       Narrow ChIP-seq peaks for consolidated epigenomes

  hotspot.fdr0.01.peaks.bed.gz        Narrow DNasePeaks for consolidated epigenomes

  hotspot.all.peaks.bed.gz            Narrow DNasePeaks for consolidated epigenomes

  .macs2.narrowPeak.gz                Narrow DNasePeaks for consolidated epigenomes

  coreMarks_mnemonics.bed.gz          15 state chromatin segmentations

  mCRF_FractionalMethylation.bigwig   MeDIP/MRE(mCRF) fractional methylation calls

  RRBS_FractionalMethylation.bigwig   RRBS fractional methylation calls

  WGBS_FractionalMethylation.bigwig   Whole genome bisulphite fractional methylation calls
  ------------------------------------------------------------------------------------------

For a complete pipeline with Chip-seq data, Bioconductor provides excellent tutorials to work with ChIP-seq and we encourage our readers to review the following article ^[@ref-66]^.

The first step shown in [Listing 24](#l24){ref-type="other"} is to download the chip-seq data. The function *query* received as argument the annotationHub database (ah) and a list of keywords to be used for searching the data, *EpigenomeRoadmap* is selecting the roadmap database, *consolidated* is selecting only the consolidate epigenomes, *brain* is selecting the brain samples, E068 is one of the epigenomes for brain (keywords can be seen in the [summary table](https://docs.google.com/spreadsheets/d/1yikGx4MsO9Ei36b64yOy9Vb6oPC5IBGlFbYEt-N6gOM/edit?pref=2&pli=1#gid=15)) and narrowPeak is selecting the type of file. The data downloaded is a processed data from an integrative Analysis of 111 reference human epigenomes ^[@ref-67]^.

1 library (AnnotationHub) 2 library (pbapply) 3 \#------------------------------------ Working with ChipSeq data ------------------------------ 4 \# Step 1: download histone marks for a brain samples. 5 \#------------------------------------------------------------------------------------------------------------------------ 6 ah = AnnotationHub() \# loading annotation hub database 7 8 \# Searching for brain consolidated epigenomes in the roadmap database 9 bpChipEpi \_ brain \<-- query(ah, c ( \"EpigenomeRoadMap\" , \"narrowPeak\" , \"chip\" , \"consolidated\" , \"brain\" , \"E068\" )) 10 11 \# Get chip--seq data 12 histone.marks \<-- pblapply( names (bpChipEpi \_ brain), function (x){ah\[\[x\]\]}) 13 names (histone.marks) \<-- names (bpChipEpi \_ brain)

**Listing 24. Download chip-seq data**

The [Chipseeker](http://bioconductor.org/packages/ChIPseeker) package ^[@ref-68]^ implements functions that uses Chip-seq data to retrieve the nearest genes around the peak, to annotate genomic region of the peak, among others. Also, it provides several visualization functions to summarize the coverage of the peak, average profile and heatmap of peaks binding to TSS regions, genomic annotation, distance to TSS and overlap of peaks or genes.

After downloading the histone marks (see [Listing 24](#l24){ref-type="other"}), it is useful to verify the average profile of peaks binding to hypomethylated and hypermethylated regions, which will help the user understand better the regions found. [Listing 25](#l25){ref-type="other"} shows an example of code to plot the average profile. [Figure 14](#f14){ref-type="fig"} shows the result.

To help the user better understand the regions found in the DMR analysis, we downloaded histone marks specific for brain tissue using the AnnotationHub package that can access the Roadmap database ( [Listing 24](#l24){ref-type="other"}). Next, the Chipseeker was used to visualize how histone modifications are enriched onto hypomethylated and hypermethylated regions, ( [Listing 25](#l25){ref-type="other"}). The enrichment heatmap and the average profile of peaks binding to those regions is shown in [Figure 14](#f14){ref-type="fig"} and [Figure 15](#f15){ref-type="fig"} respectively.

The hypomethylated and hypermethylated regions are enriched for H3K4me3, H3K9ac, H3K27ac and H3K4me1 which indicates regions of enhancers, promoters and increased activation of genomic elements. However, these regions are associated neither with transcribed regions nor Polycomb repression as the H3K36me3 and H3K27me3 heatmaps does not show an enrichment nearby the position 0, and the average profile also does not show a peak at position 0.

1 library (ChIPseeker) 2 library (pbapply) 3 library (SummarizedExperiment) 4 library (GenomeInfoDb) 5 library (ggplot2) 6 library (AnnotationHub) 7 8 \# Create a GR object based on the hypo / hypermethylated probes. 9 probes \<-- keepStandardChromosomes(rowRanges(met.chr9)\[values(met.chr9)\[, \"status.Glioblastoma Multiforme.Brain Lower Grade Glioma\" \] %in% c ( \"Hypermethylated\", \"Hypomethylated\" ),\]) 10 \# Defining a window of 3kbp -- 3kbp \_ probe \_ 3kbp 11 probes\@ranges \<-- IRanges( start = c (probes\@ranges\@start -- 3000), end = c (probes\@ranges\@start + 3000)) 12 13 \#\#\# Profile of ChIP peaks binding to TSS regions 14 \# First of all, for calculate the profile of ChIP peaks binding to TSS regions, we should 15 \# prepare the TSS regions, which are defined as the flanking sequence of the TSS sites. 16 \# Then align the peaks that are mapping to these regions, and generate the tagMatrix. 17 tagMatrixList \<-- pblapply(histone.marks, function (x) { 18 getTagMatrix(keepStandardChromosomes(x), windows = probes, weightCol = \"score\" ) 19 }) 20 names (tagMatrixList) \<-- basename (bpChipEpi \_ brain \$title ) 21 names (tagMatrixList) \<-- gsub ( \".narrowPeak.gz\" , \"\" , names (tagMatrixList)) \# remove file type from name 22 names (tagMatrixList) \<-- gsub ( \"E068--\" , \"\" , names (tagMatrixList)) \# remove file type from name 23 24 pdf( \"chip \_ heatmap.pdf\" , height = 5, width = 10) 25 tagHeatmap(tagMatrixList, xlim= c (--3000, 3000),color = NULL) 26 dev . off () 27 28 p \<-- plotAvgProf(tagMatrixList, xlim = c (--3000,3000), xlab = \"Genomic Region (5\'--\>3\', centered on CpG)\" ) 29 \# We are centreing in the CpG instead of the TSS. So we'll change the labels manually 30 p \<-- p + scale\_ x \_ continuous(breaks= c (--3000,--1500,0,1500,3000), labels = c (--3000,--1500, \"CpG\" ,1500,3000)) 31 library (ggthemes) 32 pdf( \"chip--seq.pdf\" , height = 5, width = 7) 33 p + theme \_ few() + scale\_ colour \_ few(name= \"Histone marks\" ) +guides(colour = guide \_legend (override.aes = list (size=4))) 34 dev.off ()

**Listing 25. Average profile plot**

![Average profiles for histone markers H3K27ac, H3K27me3, H3K36me3, H3K4me1, H3K4me3, H3K9ac, and H3K9me3.\
The figure indicates that the differentially methylated regions overlaps regions of enhancers, promoters and increased activation of genomic elements.](f1000research-5-11063-g0013){#f14}

![Heatmap of histone marks H3K4me1, H3K4me3, H3K27ac, H3K9ac, H3K9me3, H3K27me3 and H3K36me3 for brain tissues.\
The figure indicates that the most of the peaks that overlaps the probes are not brain specific.](f1000research-5-11063-g0014){#f15}

To annotate the location of a given peak in terms of genomic features, annotatePeak assigns peaks to genomic annotation in "annotation" column of the output, which includes whether a peak is in the TSS, Exon, 5' UTR, 3' UTR, Intronic or Intergenic location.

1 require (TxDb.Hsapiens.UCSC.hg19.knownGene) 2 txdb \<-- TxDb.Hsapiens.UCSC.hg19.knownGene 3 peakAnno \<-- annotatePeak(probes, tssRegion= c (−3000, 3000), TxDb=txdb, annoDb= \"org.Hs.eg.db\" ) 4 plotAnnoPie(peakAnno)

**Listing 26. Annotate the location of a given peak in terms of genomic features**

![Feature distribution: annotation the region of the probes.](f1000research-5-11063-g0015){#f16}

***Identification of Regulatory Enhancers.*** Recently, many studies suggest that enhancers play a major role as regulators of cell-specific phenotypes leading to alteration in transcriptomes realated to diseases ^[@ref-69]--\ [@ref-72]^. In order to investigate regulatory enhancers that can be located at long distances upstream or downstream of target genes Bioconductor offer the [Enhancer Linking by Methylation/Expression Relationship (ELMER)](http://bioconductor.org/packages/ELMER/) package. This package is designed to combine DNA methylation and gene expression data from human tissues to infer multi-level cis-regulatory networks. It uses DNA methylation to identify enhancers and correlates their state with expression of nearby genes to identify one or more transcriptional targets. Transcription factor (TF) binding site analysis of enhancers is coupled with expression analysis of all TFs to infer upstream regulators. This package can be easily applied to TCGA public available cancer data sets and custom DNA methylation and gene expression data sets ^[@ref-73]^.

[ELMER](http://bioconductor.org/packages/ELMER/) analysis have 5 main steps: 1.Identify distal enhancer probes on HM450K.2.Identify distal enhancer probes with significantly different DNA methylation level in control group and experiment group.3.Identify putative target genes for differentially methylated distal enhancer probes.4.Identify enriched motifs for the distal enhancer probes which are significantly differentially methylated and linked to putative target gene.5.Identify regulatory TFs whose expression associate with DNA methylation at motifs.

This section shows how to use ELMER to analyze TCGA data using as example LGG and GBM samples.

***Preparing the data for [ELMER](http://bioconductor.org/packages/ELMER/) package.*** After downloading the data with TCGAbiolinks package, some steps are still required to use TCGA data with [ELMER](http://bioconductor.org/packages/ELMER/). These steps can be done with the function *TCGAprepare_elmer*. This function for the DNA methylation data will remove probes with NA values in more than 20% samples and remove the annotation data, for RNA expression data it will take the log2(expression + 1) of the expression matrix in order to linearize the relation between DNA methylation and expression. Also, it will prepare the row names of the matrix as required by the package.

The [Listing 27](#l27){ref-type="other"} shows how to use [TCGAbiolinks](http://bioconductor.org/packages/TCGAbiolinks/) ^[@ref-8]^ to search, download and prepare the data for the [ELMER](http://bioconductor.org/packages/ELMER/) package. Due to time and memory constraints, we will use in this example only data from 10 LGG patients and 10 GBM patients that have both DNA methylation and gene expression data. This samples are the same used in the previous steps.

1 \#\-\-\-\-\-\-\-\-\-\-- 8.3 Identification of Regulatory Enhancers \-\-\-\-\-\-- 2 library (TCGAbiolinks) 3 library (stringr) 4 \# Samples: primary solid tumor w / DNA methylation and gene expression 5 matched \_ met \_exp \<- function (project, n = NULL){ 6 \# get primary solid tumor samples: DNA methylation 7 message ( \"Download DNA methylation information\" ) 8 met450k \<- GDCquery(project = project, 9 data . category = \"DNA methylation\", 10 platform = \"Illumina Human Methylation 450\", 11 legacy = TRUE, 12 sample .type = c ( \"Primary solid Tumor\" )) 13 met450k.tp \<- met450k \$ results\[\[1\]\] \$ cases 14 15 \# get primary solid tumor samples: RNAseq 16 message( \"Download gene expression information\" ) 17 exp \<- GDCquery(project = project, 18 data . category = \"Gene expression\" , 19 data .type = \"Gene expression quantification\" , 20 platform = \"Illumina HiSeq\" , 21 file .type = \"results\" , 22 sample .type = c( \"Primary solid Tumor\") , 23 legacy = TRUE) 24 exp .tp \<- exp \$ results\[\[1\]\] \$ cases 25 print ( exp .tp\[1:10\]) 26 \# Get patients with samples in both platforms 27 patients \<- unique( substr( exp .tp,1,15)\[ substr( exp .tp,1,12) %in% substr (met450k.tp,1,12)\]) 28 if ( !is . null (n)) patients \<- patients\[1:n\] \# get only n samples 29 return (patients) 30 } 31 lgg.samples \<- matched \_ met \_exp ( \"TCGA-LGG\" , n = 10) 32 gbm.samples \<- matched \_ met \_exp ( \"TCGA-GBM\" , n = 10) 33 samples \<- c (lgg.samples,gbm.samples) 34 35 \#\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-- 36 \# 1 - Methylation 37 \#\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-- 38 query.lgg \<- GDCquery(project = \"TCGA-LGG\" , 39 data. category = \"DNA methylation\" , 40 platform = \"Illumina Human Methylation 450\" , 41 legacy = TRUE, 42 barcode = lgg.samples) 43 GDCdownload(query.lgg) 44 met.lgg \<-GDCprepare(query.lgg, save = FALSE) 45 46 query.gbm \<- GDCquery(project = \"TCGA-GBM\" , 47 data. category = \"DNA methylation\", 48 platform = \"Illumina Human Methylation 450\", 49 legacy = TRUE, 50 barcode = gbm.samples) 51 GDCdownload(query.gbm) 52 met.gbm \<- GDCprepare(query.gbm, save = FALSE) 53 met.elmer \<- SummarizedExperiment:: cbind (met.lgg, met.gbm) 54 met.elmer \<- TCGAprepare \_ elmer(met.elmer, 55 platform = \"HumanMethylation450\" ) 56 57 \#\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-- 58 \# 2 - Expression 59 \# \-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-- 60 query. exp .lgg \<- GDCquery(project = \"TCGA-LGG\" , 61 data. category = \"Gene expression\", 62 data .type = \"Gene expression quantification\" , 63 platform = \"Illumina HiSeq\" , 64 file .type = \"results\" , 65 legacy = TRUE, barcode = lgg.samples ) 66 GDCdownload(query. exp .lgg) 67 exp .lgg \<- GDCprepare(query. exp .lgg, save = FALSE) 68 69 query. exp.gbm \<- GDCquery(project = \"TCGA-GBM\" , 70 data. category = \"Gene expression\" , 71 data.type = \"Gene expression quantification\", 72 platform = \"Illumina HiSeq\" , 73 file.type = \"results\" , 74 legacy = TRUE, barcode = gbm.samples) 75 GDCdownload(query. exp .gbm) 76 exp.gbm \<-GDCprepare(query. exp.gbm, save = FALSE) 77 exp.elmer \<- SummarizedExperiment:: cbind( exp .lgg, exp .gbm) 78 exp .elmer \<- TCGAprepare \_ elmer( exp .elmer, platform = \"IlluminaHiSeq \_ RNASeqV2\")

**Listing 27. Preparing TCGA data for ELMER's mee object**

Finally, the [ELMER](http://bioconductor.org/packages/ELMER/) input is a mee object that contains a DNA methylation matrix, an gene expression matrix, a probe information GRanges, the gene information GRanges and a data frame summarizing the data. It should be highlighted that samples without both the gene expression and DNA methylation data will be removed from the mee object.

By default the function *fetch.mee* that is used to create the mee object will separate the samples into two groups, the control group (normal samples) and the experiment group (tumor samples), but the user can relabel the samples to compare different groups. For the next sections, we will work with both the experimental group (LGG) and control group (GBM).

1 library (ELMER) 2 geneAnnot \<-- txs() 3 geneAnnot \$ GENEID \<-- paste0( \"ID\" ,geneAnnot \$ GENEID) 4 geneInfo \<-- promoters(geneAnnot,upstream = 0, downstream = 0) 5 probe \<-- get .feature.probe() 6 7 \# create mee object, use @ to access the matrices inside the object 8 mee \<-- fetch.mee(meth = met.elmer, exp = exp .elmer, 9 TCGA = TRUE, probeInfo = probe, geneInfo = geneInfo) 10 11 \# Relabel GBM samples in the mee object: GBM is control 12 mee\@sample \$ TN\[mee\@sample \$ ID %in% lgg.samples\] \<-- \"Control\"

**Listing 28. Creating mee object with TCGA data to be used in ELMER**

***ELMER analysis.*** After preparing the data into a *mee* object, we executed the five [ELMER](http://bioconductor.org/packages/ELMER/) steps for both the hypo (distal enhancer probes hypomethylated in the LGG group) and hyper (distal enhancer probes hypermethylated in the LGG group) direction. The code is shown below. A description of how these distal enhancer probes are identified is found in the [ELMER.data](https://bioconductor.org/packages/release/data/experiment/vignettes/ELMER.data/inst/doc/vignettes.pdf) vignette.

1 library (parallel) 2 \# Available directions are hypo and hyper, we will use only hypo 3 \# due to speed constraint 4 direction \<-- c ( \"hyper\" ) 5 6 for (j in direction){ 7 print (j) 8 dir .out \<-- paste0( \"elmer / \" ,j) 9 dir . create ( dir .out, recursive = TRUE) 10 \#---------------------------------------------------------------------------- 11 \# STEP 3: Analysis \| 12 \#---------------------------------------------------------------------------- 13 \# Step 3.1: Get diff methylated probes \| 14 \#---------------------------------------------------------------------------- 15 Sig.probes \<-- get . diff .meth(mee, cores=detectCores(), 16 dir .out = dir .out, 17 diff . dir =j, 18 pvalue = 0.01) 19 20 \#-------------------------------------------------------------------------------------------------------------------------- 21 \# Step 3.2: Identify significant probe--gene pairs \| 22 \#-------------------------------------------------------------------------------------------------------------------------- 23 \# Collect nearby 20 genes for Sig.probes 24 nearGenes \<-- GetNearGenes(TRange=getProbeInfo(mee, probe=Sig.probes \$ probe), 25 cores=detectCores(), 26 geneAnnot=getGeneInfo(mee)) 27 28 pair \<-- get .pair(mee=mee, 29 probes= na . omit (Sig.probes \$ probe), 30 nearGenes=nearGenes, 31 permu. dir =paste0( dir .out, \" / permu\" ), 32 dir .out= dir .out, 33 cores=detectCores(), 34 label= j, 35 permu.size=100, \# For significant results use 10000 36 Pe = 0.01) \# For significant results use 0.001 37 38 Sig.probes.paired \<-- fetch.pair(pair=pair, 39 probeInfo = getProbeInfo(mee), 40 geneInfo = getGeneInfo(mee)) 41 Sig.probes.paired \<--read . csv (paste0( dir .out, 42 \" / getPair.\" ,j, 43 \".pairs.significant.csv\" ), 44 stringsAsFactors=FALSE)\[,1\] 45 46 47 \#-------------------------------------------------------------------------------------------------------------------------- 48 \# Step 3.3: Motif enrichment analysis on the selected probes \| 49 \#-------------------------------------------------------------------------------------------------------------------------- 50 if ( length (Sig.probes.paired) \> 0){ 51 \#-------------------------------------------------------------------------------------------------------------------------- 52 \# Step 3.3: Motif enrichment analysis on the selected probes \| 53 \#-------------------------------------------------------------------------------------------------------------------------- 54 enriched.motif \<-- get .enriched.motif(probes=Sig.probes.paired, 55 dir .out= dir .out, label=j, 56 background.probes = probe \$ name) 57 motif.enrichment \<-- read . csv (paste0( dir .out, 58 \" / getMotif.\" ,j, 59 \".motif.enrichment.csv\" ), 60 stringsAsFactors=FALSE) 61 if ( length (enriched.motif) \> 0){ 62 \#-------------------------------------------------------------------------------------------------------------------------- 63 \# Step 3.4: Identifying regulatory TFs \| 64 \#-------------------------------------------------------------------------------------------------------------------------- 65 print ( \"get.TFs\" ) 66 67 TF \<-- get .TFs(mee = mee, 68 enriched.motif = enriched.motif, 69 dir .out = dir .out, 70 cores = detectCores(), label = j) 71 TF.meth. cor \<-- get ( load (paste0( dir .out, 72 \" / getTF.\" ,j, 73 \".TFs.with.motif.pvalue.rda\" ))) 74 save (TF, enriched.motif, Sig.probes.paired, 75 pair, nearGenes, Sig.probes, 76 motif.enrichment, TF.meth. cor , 77 file =paste0( dir .out, \" / ELMER \_ results \_ \" ,j, \".rda\" )) 78 } 79 } 80 }

**Listing 29. Running ELMER analysis**

When [ELMER](http://bioconductor.org/packages/ELMER/) Identifies the enriched motifs for the distal enhancer probes which are significantly differentially methylated and linked to putative target gene, it will plot the Odds Ratio (x axis) for the each motifs found. The list of motifs for the hyper direction (probes hypermethylated in LGG group compared to the GBM group) is found in the [Figure 17](#f17){ref-type="fig"}. We selected motifs that had a minimum incidence of 10 in the given probes set and the smallest lower boundary of 95% confidence interval for Odds Ratio of 1.1. These both values are the default from the ELMER package.

![The plot shows the Odds Ratio (x axis) for the selected motifs.\
The range shows the 95% confidence interval for each Odds Ratio.](f1000research-5-11063-g0016){#f17}

The analysis found 16 enriched motifs for the hyper direction and no enriched motifs for the hypo direction. After finding the enriched motifs, [ELMER](http://bioconductor.org/packages/ELMER/) identifies regulatory transcription factors (TFs) whose expression is associated with DNA methylation at motifs. [ELMER](http://bioconductor.org/packages/ELMER/) automatically creates a TF ranking plot for each enriched motif. This plot shows the TF ranking plots based on the association score ( *−log*( *Pvalue*)) between TF expression and DNA methylation of the motif. We can see in [Figure 18](#f18){ref-type="fig"} that the top three TFs that are associated with that FOX motif are FOXD3, HMGA2 and HIST1H2BH.

![TF ranking plots based on the score ( *-log*( *Pvalue*)) of association between TF expression and DNA methylation of the FOX motif.\
The dashed line indicates the boundary of the top 5% association scores and the TFs within this boundary were considered candidate upstream regulators. The top three associated TFs and the TF family members (dots in red) that are associated with that specific motif are labeled in the plot.](f1000research-5-11063-g0017){#f18}

The output of this step is a data frame with the following columns: 1.motif: the names of motif.2.top.potential.TF: the highest ranking upstream TFs which are known recognized the motif.3.potential.TFs: TFs which are within top 5% list and are known recognized the motif. top5percent: all TFs which are within top 5% list considered candidate upstream regulators

Also, for each motif we can take a look at the three most relevant TFs. For example, [Figure 19](#f19){ref-type="fig"} shows the average DNA methylation level of sites with the FOX motif plotted against the expression of the TFs FOXD3, HIST1H1D, HIST1H2BH and HMGA2. We can see that the experiment group (LGG samples) has a lower average methylation level of sites with the FOX motif plotted and a higher average expression of the TFs.

![Each scatter plot shows the average DNA methylation level of sites with the FOX motif plotted against the expression of the TFs FOXD3, HIST1H1D, HIST1H2BH, HMGA2 respectively.](f1000research-5-11063-g0018){#f19}

1 scatter. plot (mee, category = \"TN\" , save =T, lm\_ line=TRUE, 2 byTF= list (TF= c ( \"FOXD3\" , \"HIST1H1D\" , \"HIST1H2BH\" , \"HMGA2\" ), 3 probe=enriched.motif\[\[ \"FOX\" \]\]))

**Listing 30. Visualizing the average DNA methylation level of sites with a chosen motif vs TF expression**

And for each relevant TF we will use the clinical data to analyze the survival curves for the 30% patients with higher expression of that TF versus the 30% with lower expression. The code below shows that analysis.

1 TCGAsurvival \_ TFplot \<-- function (TF,mee, clinical, percentage = 0.3){ 2 3 \# For the transcription factor, gets it getGeneID 4 gene \<-- getGeneID(mee, symbol =TF) 5 \# Get the expression values for the genes. 6 \# (getExp is a ELMER function) 7 exp \<-- getExp(mee,geneID=gene) 8 9 \# Get the names of the 30% patients with lower expression 10 g1 \<-- names ( sort ( exp )\[1: ceiling ( length ( exp ) ∗ percentage)\]) 11 12 \# Get the names of the 30% patients with higher expression 13 g2 \<-- names ( sort ( exp , decreasing = T)\[1: ceiling ( length ( exp ) ∗ percentage)\]) 14 15 \# get the data of only these patients 16 idx \<-- clinical \$ bcr \_ patient \_ barcode %in% substr ( c (g1, g2),1,12) 17 clinical \<-- clinical\[idx,\] 18 \# Create the labels for each sample 19 clinical \$ tf \_ groups \<-- \"high\" 20 low.idx \<-- clinical \$ bcr \_ patient \_ barcode %in% substr ( c (g1),1,12) 21 clinical\[low.idx,\] \$ tf \_ groups \<-- \"low\" 22 23 \# Use TCGAbiolinks to create the survival curve 24 TCGAanalyze \_ survival(clinical, \"tf \_ groups\" , 25 legend =paste0(TF, \"Exp level\" ), 26 filename = paste0(TF, \".pdf\" )) 27 } 28 29 \# get clinical patient data for GBM samples 30 gbm \_ clin \<-- GDCquery \_ clinic( \"TCGA-GBM\" , \"Clinical\" ) 31 32 \# get clinical patient data for LGG samples 33 lgg \_ clin \<-- GDCquery \_ clinic( \"TCGA-LGG\" , \"Clinical\" ) 34 35 \# Bind the results, as the columns might not be the same, 36 \# we will will plyr rbind.fill, to have all columns from both files 37 clinical \<-- plyr:: rbind .fill(gbm \_ clin,lgg \_ clin) 38 \# Call the function we created 39 TCGAsurvival \_ TFplot( \"ELF4\" ,mee,clinical) 40 TCGAsurvival \_ TFplot( \"HMGA2\" ,mee,clinical) 41 TCGAsurvival \_ TFplot( \"FOXD3\" ,mee,clinical)

**Listing 31. Survival analysis for samples with both lower and higher expression of regulatory TFs.**

The [Figure 20](#f20){ref-type="fig"}, shows that the samples with lower expression of some of these TFs have a better survival than those with higher expression.

![**A**) Survival plot for the 30% patients with high expression and low expression of ELF4 TF. **B**) Survival plot for the 30% patients with high expression and low expression of HGMA2 TF.](f1000research-5-11063-g0019){#f20}

Conclusion
==========

This workflow outlines how one can use specific Bioconductor packages for the analysis of cancer genomics and epigenomics data derived from the TCGA. In addition, we highlight the importance of using ENCODE and Roadmap data to inform on the biology of the non-coding elements defined by functional roles in gene regulation. We introduced [TCGAbiolinks](http://bioconductor.org/packages/TCGAbiolinks/) and [RTCGAToolbox](http://bioconductor.org/packages/RTCGAToolbox/) Bioconductor packages in order to illustrate how one can acquire TCGA specific data, followed by key steps for genomics analysis using [GAIA](http://bioconductor.org/packages/gaia/) package, for transcriptomic analysis using [TCGAbiolinks](http://bioconductor.org/packages/TCGAbiolinks/), dnet, [pathview](http://bioconductor.org/packages/pathview/) packages and for DNA methylation analysis using [TCGAbiolinks](http://bioconductor.org/packages/TCGAbiolinks/) package. An inference of gene regulatory networks was also introduced by [MINET](http://bioconductor.org/packages/minet/) package. Finally, we introduced Bioconductor packages [AnnotationHub](http://bioconductor.org/packages/AnnotationHub/), [ChIPSeeker](http://bioconductor.org/packages/ChIPseeker/), [ComplexHeatmap](http://bioconductor.org/packages/ComplexHeatmap/), and [ELMER](http://bioconductor.org/packages/ELMER/) to illustrate how one can acquire ENCODE/Roadmap data and integrate these data with the results obtained from analyzing TCGA data to identify and characterize candidate regulatory enhancers associated with cancer.

Data and software availability
==============================

This workflow depends on various packages from version 3.2 of the Bioconductor project, running on R version 3.2.2 or higher. It requires a number of software packages, including [AnnotationHub](http://bioconductor.org/packages/AnnotationHub/), [ChIPSeeker](http://bioconductor.org/packages/ChIPseeker/), [ELMER](http://bioconductor.org/packages/ELMER/), [ComplexHeatmap](http://bioconductor.org/packages/ComplexHeatmap/), [GAIA](http://bioconductor.org/packages/gaia/), [rGADEM](http://bioconductor.org/packages/rGADEM/), [MotIV](http://bioconductor.org/packages/MotIV/), [MINET](http://bioconductor.org/packages/minet/), [RTCGAToolbox](http://bioconductor.org/packages/RTCGAToolbox/) and [TCGAbiolinks](http://bioconductor.org/packages/TCGAbiolinks/). Version numbers for all packages used are in section \"Session Information\". [Listing 32](#l32){ref-type="other"} shows how to install all the required packages.

1 source ( \"https: // bioconductor.org / biocLite.R\" ) 2 packages \<-- c ( \"TCGAbiolinks\" , \"ELMER\" , \"gaia\" , \"ChIPseeker\" , 3 \"AnnotationHub\" , \"ComplexHeatmap\" , 4 \"clusterProfiler\" , \"RTCGAToolbox\" , 5 \"minet\" , \"biomaRt\" , \"pathview\" , \"MotifDb\" , 6 \"MotIV\" , \"motifStack\" , \"rGADEM\" ) 7 new.packages \<-- packages \[ ! ( packages %in% installed . packages () \[, \"Package\" \])\] 8 if ( length ( new . packages )) biocLite( new . packages ) 9 if ( !require ( \"dnet\" )) install . packages ( \"dnet\" ) 10 if ( !require ( \"circlize\" )) install . packages ( \"circlize\" ) 11 if ( !require ( \"VennDiagram\" )) install . packages ( \"VennDiagram\" ) 12 if ( !require ( \"c3net\" )) install . packages ( \"c3net\" ) 13 if ( !require ( \"pbapply\" )) install . packages ( \"pbapply\" ) 14 if ( !require ( \"gplots\" )) install . packages ( \"gplots\" )

**Listing 32. Installing packages**

All data used in this workflow is freely available and some of them can be accessed using a R/Bioconductor package. There are three main sources of data: [The NCI Genomic Data Commons (GDC)](https://cancergenome.nih.gov/), a [supplementary data repository](http://egg2.wustl.edu/roadmap/web_portal/) with processed datasets from the Roadmap Epigenomics Project and from The Encyclopedia of DNA Elements (ENCODE) ^[@ref-67]^ and the BioGRID database with physical and genetic interactions information. For the first, a summary of the data available can be seen in <https://gdc-portal.nci.nih.gov/> and its data can be accessed using the R/Bioconductor [TCGAbiolinks](http://bioconductor.org/packages/TCGAbiolinks/) package. For the second, a summary of the data available can be found in this [spread sheet](https://docs.google.com/spreadsheets/d/1yikGx4MsO9Ei36b64yOy9Vb6oPC5IBGlFbYEt-N6gOM/edit#gid=15) and the data can be accessed using the R/Bioconductor [AnnotationHub](http://bioconductor.org/packages/AnnotationHub/) package. For the third, the data should be directly download from the data portal.

Session information
===================

1 R version 3.3.0 (2016--05--03) 2 Platform : x86 \_ 64--pc--linux--gnu (64--bit ) 3 Running under: Ubuntu 16.04.1 LTS 4 5 locale: 6 \[1\] LC \_ CTYPE= pt\_ BR.UTF--8 LC \_ NUMERIC= C 7 \[3\] LC \_ TIME= pt\_ BR.UTF--8 LC \_ COLLATE=en \_ US.UTF--8 8 \[5\] LC \_ MONETARY= pt\_ BR.UTF--8 LC \_ MESSAGES=en \_ US.UTF--8 9 \[7\] LC \_ PAPER= pt\_ BR.UTF--8 LC \_ NAME= C 10 \[9\] LC \_ ADDRESS= C LC \_ TELEPHONE= C 11 \[11\] LC \_ MEASUREMENT= pt\_ BR.UTF--8 LC \_ IDENTIFICATION= C 12 13 attached base packages : 14 \[1\] stats4 parallel grid stats graphics grDevices utils 15 \[8\] datasets methods base 16 17 other attached packages : 18 \[1\] rGADEM \_ 2.20.0 19 \[2\] seqLogo \_ 1.38.0 20 \[3\] BSgenome \_ 1.40.1 21 \[4\] rtracklayer \_ 1.32.1 22 \[5\] motifStack \_ 1.16.2 23 \[6\] ade4 \_ 1.7--4 24 \[7\] grImport \_ 0.9--0 25 \[8\] XML \_ 3.98--1.4 26 \[9\] MotIV \_ 1.28.0 27 \[10\] pathview \_ 1.12.0 28 \[11\] biomaRt \_ 2.28.0 29 \[12\] minet \_ 3.30.0 30 \[13\] clusterProfiler \_ 3.0.4 31 \[14\] DOSE \_ 2.10.7 32 \[15\] AnnotationHub \_ 2.4.2 33 \[16\] ChIPseeker \_ 1.8.7 34 \[17\] ELMER \_ 1.4.2 35 \[18\] ELMER. data\_ 1.2.2 36 \[19\] Homo.sapiens \_ 1.3.1 37 \[20\] TxDb.Hsapiens.UCSC.hg19.knownGene \_ 3.2.2 38 \[21\] org.Hs.eg.db \_ 3.3.0 39 \[22\] GO.db \_ 3.3.0 40 \[23\] OrganismDbi \_ 1.14.1 41 \[24\] GenomicFeatures \_ 1.24.5 42 \[25\] AnnotationDbi \_ 1.34.4 43 \[26\] IlluminaHumanMethylation450kanno.ilmn12.hg19 \_ 0.2.1 44 \[27\] minfi \_ 1.18.2 45 \[28\] bumphunter \_ 1.12.0 46 \[29\] locfit \_ 1.5--9.1 47 \[30\] iterators \_ 1.0.8 48 \[31\] foreach \_ 1.4.3 49 \[32\] Biostrings \_ 2.40.2 50 \[33\] XVector \_ 0.12.1 51 \[34\] SummarizedExperiment \_ 1.2.3 52 \[35\] GenomicRanges \_ 1.24.2 53 \[36\] GenomeInfoDb \_ 1.8.3 54 \[37\] IRanges \_ 2.6.1 55 \[38\] S4Vectors \_ 0.10.2 56 \[39\] lattice \_ 0.20--33 57 \[40\] Biobase \_ 2.32.0 58 \[41\] BiocGenerics \_ 0.18.0 59 \[42\] ComplexHeatmap \_ 1.10.2 60 \[43\] dnet \_ 1.0.9 61 \[44\] supraHex \_ 1.10.0 62 \[45\] hexbin \_ 1.27.1 63 \[46\] igraph \_ 1.0.1 64 \[47\] circlize \_ 0.3.7 65 \[48\] pbapply \_ 1.2--1 66 \[49\] gplots \_ 3.0.1 67 \[50\] gaia \_ 2.16.0 68 \[51\] readr \_ 0.2.2 69 \[52\] downloader \_ 0.4 70 \[53\] TCGAbiolinks \_ 2.1.0 71 72 loaded via a namespace (and not attached): 73 \[1\] SparseM \_ 1.7 ggthemes \_ 3.2.0 74 \[3\] prabclus \_ 2.2--6 GGally \_ 1.2.0 75 \[5\] R .methodsS3 \_ 1.7.1 pkgmaker \_ 0.22 76 \[7\] tidyr \_ 0.5.1 ggplot2 \_ 2.1.0 77 \[9\] knitr \_ 1.13 aroma.light \_ 3.2.0 78 \[11\] multcomp \_ 1.4--6 R .utils \_ 2.3.0 79 \[13\] data . table\_ 1.9.6 hwriter \_ 1.3.2 80 \[15\] KEGGREST \_ 1.12.2 RCurl \_ 1.95--4.8 81 \[17\] GEOquery \_ 2.38.4 doParallel \_ 1.0.10 82 \[19\] preprocessCore \_ 1.34.0 cowplot \_ 0.6.2 83 \[21\] TH. data\_ 1.0--7 RSQLite \_ 1.0.0 84 \[23\] chron \_ 2.3--47 xml2 \_ 1.0.0 85 \[25\] httpuv \_ 1.3.3 assertthat \_ 0.1 86 \[27\] BiocInstaller \_ 1.22.3 DEoptimR \_ 1.0--6 87 \[29\] caTools \_ 1.17.1 dendextend \_ 1.2.0 88 \[31\] Rgraphviz \_ 2.16.0 DBI \_ 0.4--1 89 \[33\] geneplotter \_ 1.50.0 reshape \_ 0.8.5 90 \[35\] stringdist \_ 0.9.4.1 EDASeq \_ 2.6.2 91 \[37\] matlab \_ 1.0.2 dplyr \_ 0.5.0 92 \[39\] trimcluster \_ 0.1--2 annotate \_ 1.50.0 93 \[41\] gridBase \_ 0.4--7 robustbase \_ 0.92--6 94 \[43\] GenomicAlignments \_ 1.8.4 mclust \_ 5.2 95 \[45\] mnormt \_ 1.5--4 cluster \_ 2.0.4 96 \[47\] ape \_ 3.5 genefilter \_ 1.54.2 97 \[49\] edgeR \_ 3.14.0 nlme \_ 3.1--128 98 \[51\] nnet \_ 7.3--12 diptest \_ 0.75--7 99 \[53\] sandwich \_ 2.3--4 registry \_ 0.3 100 \[55\] affyio \_ 1.42.0 matrixStats \_ 0.50.2 101 \[57\] graph \_ 1.50.0 rngtools \_ 1.2.4 102 \[59\] base64 \_ 2.0 Matrix \_ 1.2--6 103 \[61\] boot \_ 1.3--18 zoo \_ 1.7--13 104 \[63\] whisker \_ 0.3--2 GlobalOptions \_ 0.0.10 105 \[65\] png \_ 0.1--7 rjson \_ 0.2.15 106 \[67\] bitops \_ 1.0--6 R .oo \_ 1.20.0 107 \[69\] ConsensusClusterPlus \_ 1.36.0 KernSmooth \_ 2.23--15 108 \[71\] doRNG \_ 1.6 shape \_ 1.4.2 109 \[73\] stringr \_ 1.0.0 qvalue \_ 2.4.2 110 \[75\] nor1mix \_ 1.2--1 coin \_ 1.1--2 111 \[77\] ShortRead \_ 1.30.0 scales \_ 0.4.0 112 \[79\] GSEABase \_ 1.34.0 magrittr \_ 1.5 113 \[81\] plyr \_ 1.8.4 gdata \_ 2.17.0 114 \[83\] zlibbioc \_ 1.18.0 RColorBrewer \_ 1.1--2 115 \[85\] illuminaio \_ 0.14.0 plotrix \_ 3.6--3 116 \[87\] KEGGgraph \_ 1.30.0 lme4 \_ 1.1--12 117 \[89\] Rsamtools \_ 1.24.0 affy \_ 1.50.0 118 \[91\] MASS \_ 7.3--45 stringi \_ 1.1.1 119 \[93\] GOSemSim \_ 1.30.3 latticeExtra \_ 0.6--28 120 \[95\] ggrepel \_ 0.5 tools \_ 3.3.0 121 \[97\] gridExtra \_ 2.2.1 sjPlot \_ 2.0.1 122 \[99\] digest \_ 0.6.9 shiny \_ 0.13.2 123 \[101\] quadprog \_ 1.5--5 fpc \_ 2.1--10 124 \[103\] Rcpp \_ 0.12.6 siggenes \_ 1.46.0 125 \[105\] httr \_ 1.2.1 psych \_ 1.6.6 126 \[107\] kernlab \_ 0.9--24 effects\_ 3.1--1 127 \[109\] sjstats \_ 0.2.0 colorspace \_ 1.2--6 128 \[111\] rvest \_ 0.3.2 topGO \_ 2.24.0 129 \[113\] splines \_ 3.3.0 RBGL \_ 1.48.1 130 \[115\] multtest \_ 2.28.0 flexmix \_ 2.3--13 131 \[117\] xtable \_ 1.8--2 jsonlite \_ 1.0 132 \[119\] nloptr \_ 1.0.4 UpSetR \_ 1.2.2 133 \[121\] modeltools \_ 0.2--21 R6 \_ 2.1.2 134 \[123\] htmltools \_ 0.3.5 mime \_ 0.5 135 \[125\] minqa \_ 1.2.4 BiocParallel \_ 1.6.3 136 \[127\] DESeq \_ 1.24.0 class\_ 7.3--14 137 \[129\] interactiveDisplayBase \_ 1.10.3 beanplot \_ 1.2 138 \[131\] codetools \_ 0.2--14 mvtnorm \_ 1.0--5 139 \[133\] tibble \_ 1.1 gtools \_ 3.5.0 140 \[135\] openssl \_ 0.9.4 survival \_ 2.39--5 141 \[137\] limma \_ 3.28.17 munsell \_ 0.4.3 142 \[139\] DO.db \_ 2.9 GetoptLong \_ 0.1.3 143 \[141\] sjmisc \_ 1.8 haven \_ 0.2.1 144 \[143\] reshape2 \_ 1.4.1 gtable \_ 0.2.0

We are grateful to all the authors of the packages used in this article. Also, we would like to thank The GDC Support Team for the provided help, which was necessary in order to update the TCGAbiolinks package to use GDC API.
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Version 2

This article provides a comprehensive overview of how to query, download and analyze data from large cancer consortia using R and Bioconductor. Overall, I find it a useful contribution to the field, and it illustrates many of the use cases that will likely be of interest to other researchers. However, as it currently is, I find that it suffers from a few problems that I think that the authors could relatively easily fix.

Most importantly, it should be asserted that all the code actually runs. For example, the code in listings 2 and 4 will not run since the functions are capitalized in the wrong way, and the code in listing 7 will not work since the \"lastDate\" variable is not defined. Also, the session info does not seem to correspond to the same session as was used in the workflow since, for example, the RTCGAToolbox package is not listed as being loaded. 

Also, as the code is currently provided (in listings, with row numbers), I could not find a way to directly cut and paste it into an R session. Given the amount of code included in this workflow, it would be good if that could be resolved. 

Since the workflow contains a lot of code, it would be useful to add a bit more comments, explaining what each code chunk, and each part of a chunk, is doing. Moreover, the different code chunks have different formatting styles, and it would be easier to read if this was harmonized. For example, comments are formatted differently, spaces are used inconsistently, and even within a listing (e.g., listing 2) the function calls use different formatting (with or without named arguments). Finally, not all code chunks are in \"listings\", and it is not clear to me why. 

Throughout the text, the authors should also make sure to be consistent in terms of capitalization. In several places there are differences in capitalization between the text and the code (e.g., GDCquery_Maf()), or between different places in the text. There are also discrepancies in whether function names are italicized or not. The function GDCquery_clinic is referred to as GDCquery_clinical in the text. Within one section, the AAIC is spelled out as \"Array Array\", \"Array-array\" and \"array-array\".

Just after listing 2, it is stated that you can use \"rowRanges to gets the range of values in each row\" of the SummarizedExperiment object. This should be clarified, since it returns a GRanges object describing the features in the rows. 

The \"p-value corrected FDR\" should also be replaced by e.g. \"corrected (or adjusted) p-value\" or \"FDR\". 

Bioconductor should be capitalized. 

The \"broadinstitute website\" should be changed to \"Broad Institute website\" and include a link.

The \"nce\" is not defined as far as I could see, and the sentence just before the \"Retrieving known interactions\" seems unfinished. It is not clear to me how the information that \"There are 3,941 unique interactions between the 2,901 differentially expressed genes\" was obtained, since the function in the code chunk above is not run until later. 

It would be easier to get an overview of the text of the headers were more consistent. For example, the gene regulatory network section has subheaders that are larger than the main section header. 

Finally, as mentioned by one of the other reviewers, the paper would benefit from modifications to the text in order to make it more readable. There are many grammatical errors, long and complicated sentences, and sentences that are unfinished and thus difficult to understand. 

I believe that if the authors can make sure that all the code in the workflow runs as expected, and the text and code is clarified and harmonized throughout the manuscript, this can be a very valuable addition to the literature.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
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Version 1

As it has been pointed out already by the first reviewer, it is important to verify that the pipeline is updated according to the data migration to the GCD server.

Apart from this, I find this manuscript very nice and the workflow an important contribution in the field, allowing to make accessible large datasets with genomics profiling of cancer patients to the community and even for not advanced R-users. I would like to compliment with the authors to make such a comprehensive workflow available.

Some minor points before final publication is indexed: The main issue with this manuscript is that it will need an extensive revision by a native English speaker since some sentences are hard to read and very often they risk to convey the wrong message or to be misinterpreted. One example from the abstract, \"we provide a series of biologically focused integrative downstream analyses of different molecular data\" includes to many adjectives. Few lines below \"we provide a workplan to identify candidate biologically relevant functional epigenomic elements associated with cancer\", this sentence does not sound that right in English.Be also careful in the style use to call the software or Bioconductor packages in the text since sometimes they are italics and other times they are not.There is also a lot of redundancy on some of the statements in the introduction that if removed will improve the readability. For example the sentence at the end of the first paragraph of the introduction starting with \" Here we describe a comprehensive workflow that integrates many bioconductor packages\...\" is probably not needed since the same concept is provided at the end of the introduction in the same page.In the Introduction when TCGA data are illustrated I would also mention metastatic samples (they are there, isn\'t it? or may be I don\'t recall correctly\...)I suggest to change the title of the first section of the methods from \'Experimental data\' to \'Access to the data\' or something similar so that it will better reflect the content of the paragraph.I felt that sometimes the manuscript sounds more a user guide than an article, so I would suggest taking as an example the section on methylation to improve the discussion of the analyses outcome and aims in the other paragraphs.Also please be careful to make things accessible to any readers for example at page 4, the authors introduce the GISTIC data without explaining them in details.The sentence at page 4 \"the data used in this workflow are published data and freely available\" might be redundant so the authors could remove it.Page 4 summarizedExperiment object is missing the reference to the original paper about summarizedExperiment format.Page 5: in the text the authors illustrate assay, rowRanges and colData but in the example the order is different, i.e. assay, colData, rowRanges - I would suggest to keep consistency in the order between main text and examples (it also holds for other places in the paper).I am not sure I can understand the sentence at page 5, \"the users should use all the follow up files in your analyses, not just the latest version\".Page 6: the sentence beginning with \"Finally, the Cancer Genome Atlas (TCGA) Research Network has reported integrated genome-wide studies of various diseases, in what is called \'Pan Cancer\'\...\" I am not sure fits within the paragraph where the main focus is on subtypes. It sounds a bit confusing for the reader.Not sure that Listing 5 also fits there\... why not mention it before together with the others summ.exp. accessors.In writing it is important that the authors really pay attention to convey the message that it is an integrative approach \... at the very first reading of the manuscript I felt that it was more a list of tools. and the integrative part of it was missingPage 18: a reference is missing for the AAIC method and an explanation to the reader about the choice of the 0.6 correlation cutoff.In the list at page 18 with the normalization, I believe that there are some repetitions (i.e. global scaling and full-quantile are appearing twice, also there are some typos).Page 19, I might have missed something but I cannot find in maintext any explanation of the DEA pipeline and more comments would be needed there for a new user to really appreciate it and its importance.Page 20 on the second line I believe a ). is missing.On PEA, I was wondering why for example the R package for Reactome was not integrated here and if the authors could comment on this.Page 23, why for protein-protein interactions only BioGrid is used and not for example a more comprehensive resource such as I2D (Interologous Interaction Database).

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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University of São Paulo, Brazil
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Dear Elena Papaleo,  

First, we would like to thank you for your review and for providing a detailed feedback for our workflow. We have made several changes in this new version (2) of the workflow. The changes and responses of all authors to these points are described below: \"As it has been pointed out already by the first reviewer, it is important to verify that the pipeline is updated according to the data migration to the GCD server.\" TCGAbiolinks package was entirely redesigned to query, download and prepare data from the GDC NCI data portal ( <https://gdc.nci.nih.gov/>). All the codes are working and we will submit very soon the workflow to Bioconductor. For the moment, the RMarkdown can be found in our Github repository ( <https://github.com/BioinformaticsFMRP/f1000_TCGA_Workflow/blob/master/f1000.Rmd>).\"Be also careful in the style use to call the software or Bioconductor packages in the text since sometimes they are italics and other times they are not.\" We applied the following pattern: name of the packages normal with a link to the package, name of functions and objects in italics.\"I felt that sometimes the manuscript sounds more a user guide than an article, so I would suggest taking as an example the section on methylation to improve the discussion of the analyses outcome and aims in the other paragraphs.\" Our main focus was on using the tools (in a reasonable time) rather than analyzing the results. The analysis itself can be verified with some articles of our group, for example, the DNA methylation analysis was described in Ceccarelli, Michele, *et al.* \" [Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma.](http://dx.doi.org/10.1016/j.cell.2015.12.028)\" Cell 164.3 (2016): 550-563 as well as the analysis performed by the ELMER tool which is described in Yao, Lijing, *et al.* \" [Inferring regulatory element landscapes and transcription factor networks from cancer methylomes](https://genomebiology.biomedcentral.com/articles/10.1186/s13059-015-0668-3).\" Genome biology 16.1 (2015): 1.\"In writing it is important that the authors really pay attention to convey the message that it is an integrative approach \... at the very first reading of the manuscript I felt that it was more a list of tools. and the integrative part of it was missing\" We agree with you. The article starts with specific analysis, which might cover 65% of the content and unfortunately it might lead to the feeling of the missing integrative approach. Also, we decided not to go much deeper into the analyzes because they already exist in the referenced articles and we focus more on the execution of the analyzes with the tools of the bioconductor project, something that was not covered by the cited articles, which might also give the feeling of  a \"list of tools\". But, the integrative analysis is shown strongly in the last two sections. We may highlight that ELMER, for example, uses DNA methylation, gene expression, histone marks, motif information and clinical data for its analysis. Also, after the DNA methylation analysis available in TCGAbiolinks package, we do a motif analysis on those regions and integrated the roadmap histone marks data to evaluate them. Finally, another integrative analysis presented in the TCGAbiolinks package is the starburst plot which integrates the differential expression analysis results with the DNA methylation results and we try to identify if the nearest gene might have been affected by the change of the DNA methylation.\"Page 18: a reference is missing for the AAIC method and an explanation to the reader about the choice of the 0.6 correlation cutoff.\" Array-array intensity correlation plot (AAIC) is a re-adaptation of a affyQCReport::correlationPlot working with data from gene expression of class RangedSummarizedExperiment as output of GDCprepare.Reference from <https://www.bioconductor.org/packages/devel/bioc/vignettes/affyQCReport/inst/doc/affyQCReport.pdf>. AAIC shows an heat map of the array-array Spearman / Pearson rank correlation coefficients. The arrays are ordered using the phenotypic data (if available) in order to place arrays with similar samples adjacent to each other. Self-self correlations are on the diagonal and by definition have a correlation coefficient of 1.0. Data from similar tissues or treatments will tend to have higher coefficients. This plot is useful for detecting outliers, failed hybridizations, or mistracked samples.The 0.6 threshold came out from unsupervised hierarchical clustering with ward methodology that obtained distinct groups of samples and first one had pearson correlation lower than 0.6 considering them as possible outliers.\"Page 19, I might have missed something but I cannot find in maintext any explanation of the DEA pipeline and more comments would be needed there for a new user to really appreciate it and its importance.\" For DEA pipeline we used the TCGAanalyze_DEA function from our package TCGAbiolinks, that allows user to perform Differentially expression analysis (DEA), using edgeR package to identify differentially expressed genes (DEGs). It is possible to do a two-class analysis.TCGAanalyze_DEA performs DEA using following functions from edgeR: edgeR::DGEList converts the count matrix into an edgeR object.edgeR::estimateCommonDisp each gene gets assigned the same dispersion estimate.edgeR::exactTest performs pair-wise tests for differential expression between two groups.edgeR::topTags takes the output from exactTest(), adjusts the raw p-values using the False Discovery Rate (FDR) correction, and returns the top differentially expressed genes.\"On PEA, I was wondering why for example the R package for Reactome was not integrated here and if the authors could comment on this.\" Thank you for this suggestion we are working to integrate Reactome as source of genes annotated within pathways.Our PEA provided only one plot to show Gene ontologies and pathways enriched by a list of genes to have an overview of top biological functions and pathways altered by molecules inside the gene signature. We focused mainly on Bioconductor packages, but in particular we are interested to add wrapping to some functionalities of the ReactomePA package.\"Page 23, why for protein-protein interactions only BioGrid is used and not for example a more comprehensive resource such as I2D (Interologous Interaction Database).\" Different sources for protein-protein interactions are available. We used BioGrid as an example, but the users can chose their preferred database such as I2D

Regarding the other points: We revised the text to correct links, references and remove redundancies.We added metastatic samples as one of the available sample typesWe changed the name of the section \'Experimental data\' to \'Access to the data\'We included a paragraph introducing GISTIC data
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Version 1

This review comes at a very inopportune moment. The entire software pipeline is based on the TCGAbiolinks tool kit, which downloads files from the TCGA DCC service. Unfortunately, just as this paper was being sent for review, the NCI began their migration to the GDC service. This means that all of the data services at DCC TCGA data portal (https://tcga-data.nci.nih.gov) are no longer active, and users are being directed to the GDC NCI data portal (https://gdc.nci.nih.gov/). This means that the TCGAbiolinks tool kit is broken. My attempts to run some of the examples listed in the paper where stopped by this issue. Many parts of the TCGAbiolinks will have to be fixed and/or re-written to deal with this change. This isn't the fault of the authors, but it does render the example and pipelines described in the paper inoperable.

There are a few technical issues that need to be addressed. The package 'RTCGAtoolbox' is mentioned, but actually its name is 'RTCGAToolbox'. (lower-case T to upper-case), and because the bioconductor website is case-sensitive the provided URL ( http://bioconductor.org/packages/RTCGAtoolbox/ ) doesn't work. On page 3, 'TCGA Wikipedia' should be 'TCGA Wiki'. In the methods section on page 3, where the various data levels of TCGA are explained, on the most important aspects about the different levels is of access requirements. Data levels 1 and 2 cannot be accessed without dbGap, while level 3 and 4 are generally available for public access. 

There is also the question of whether or not this paper fits the criteria of the Software Tools Article guidelines. The authors have presented a loose set of examples that utilize various existing, and previously published, tools. In the guidelines of F1000Research\'s Software Tool Articles, the criteria for a paper is "We welcome the description of new software tools. A Software Tool Article should include the rationale for the development of the tool and details of the code used for its construction."  The authors refer to the code included in the paper as a workflow, but reads more like a series of point example that the reader can copy and alter for their own research. In introducing a new piece of software, one expects that the authors of the article are responsible for the software being presented. And while this article mentioned an extensive number of R packages, I believe only one of them, TCGAbiolinks, was written by the authors, and was published last year. While the analysis they present is very detailed and covers an expansive number of topics, I'm not sure if this should be classified as 'Software Tool Article'. On my first read through, my assumption was that the authors were responsible for all of the tools mentioned in the abstract. And this wasn't clarified in the text. For example, in the conclusion section on page 43, they include the phrase 'We introduced TCGAbiolinks and RTCGAtoolbox bioconductor packages in order to illustrate how one can acquire TCGA specific data', it wasn't until later, that I realized that the author of the RTCGAToolbox wasn't in the author list of the paper. 

Of course, this is at the discretion of the editors. I would feel that this material would better be presented as a review article covering the different methods of TCGA data analysis, with better notation and attributions about the source of different pieces of software.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
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Dear Kyle Ellrott,

Thank you for your comments and suggestions. We made several changes in the version 2 of the workflow, some of the changes and answers to your points are below: TCGAbiolinks package was entirely redesigned to query, download and prepare data from the GDC NCI data portal ( <https://gdc.nci.nih.gov/>). All the codes are working and we will submit very soon the workflow to Bioconductor. For the moment, the RMarkdown can be found in our Github repository ( <https://github.com/BioinformaticsFMRP/f1000_TCGA_Workflow/blob/master/f1000.Rmd>).We also highlighted the difference between open (TCGA level 3 and 4 data) and controlled data (TCGA level 1 and 2 data) and we added some useful sources that can help the user request access to the controlled data.Despite the description of a software article, we decided by this type of article simply because there were already other workflows with that choice and we did not find any other possibility that best described this type of article. In addition, our main focus was on using the tools (in a reasonable time) rather than analyzing the results. The analysis itself can be verified with some articles of our group, for example, the DNA methylation analysis was described in **Ceccarelli, Michele, *et al*. \" [Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma.](http://dx.doi.org/10.1016/j.cell.2015.12.028)\" Cell 164.3 (2016): 550-563** as well as the analysis performed by the ELMER tool which is described in **Yao, Lijing, *et al.* \" [Inferring regulatory element landscapes and transcription factor networks from cancer methylomes](https://genomebiology.biomedcentral.com/articles/10.1186/s13059-015-0668-3).\" Genome biology 16.1 (2015): 1.**We added to \"Author contributions\" that we are the authors from the R/Bioconductor packages [TCGAbiolinks](https://bioconductor.org/packages/release/bioc/html/TCGAbiolinks.html) and [GAIA](https://bioconductor.org/packages/release/bioc/html/gaia.html). Also, I\'m working on a new version of the ELMER package.We corrected links and references such as ** ** [RTCGAToolbox](https://www.bioconductor.org/packages/devel/bioc/html/RTCGAToolbox.html).

[^1]: ^†^These authors contributed equally to this workflow

[^2]: HN conceived the study. HN, MC and GB provided direction on the design of the Transcriptomics, Genomics, master regulatory networks and DNA methylation workflows. TCS developed and tested sections \"Experimental data\", \"DNA methylation analysis\", \"Motif analysis\" and \"Integrative analysis\". AC developed and tested section \"Transcriptomic analysis\". CO developed and tested the section \"Inference of gene regulatory networks\". FDA developed and tested section \"Genomic analysis\". TCS, AC, CO, and FDA prepared the first draft of the manuscript. All authors were involved in the revision of the draft manuscript and have agreed to the final content. Also, AC, TS, CO, MC, GB and HN are authors of the TCGAbiolinks package and MC is author of the GAIA package.
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